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ABSTRACT 
 
Speaker, Elizabeth, M.S., December 2010  Health and Human Performances 
 
Evaluation of an HIV and HCV Prevention Intervention:  Taking it to Treatment Court 
 
Chairperson:  Annie Sondag 
 
  The purpose of this study was to evaluate the HIV/HCV prevention intervention, Taking 
it to Treatment Court (TITTC), which is part of the greater Yellowstone County Family 
Drug Treatment Court (YCFDTC) program.  The findings from this study will be used by 
the Montana Department of Public Health and Human Services, The Yellowstone County 
Family Drug Treatment Court, and the Montana HIV Prevention Community Planning 
Group to determine the effectiveness of TITTC and make changes as necessary.  To 
evaluate TITTC this study utilized quantitative and qualitative research methods.  
Quantitative data were collected through a Theory of Planned Behavior survey and an 
HIV and HCV knowledge questionnaire.  Participants of TITTC were given the survey 
instrument pre intervention, two weeks post intervention, and again at a three month 
follow up.  Urinalysis and arrest report data were also collected from YCFDTC and 
compared to self report data.  Qualitative data were collected through two focus groups 
with past participants of TITTC. Results of this study indicate that the TITTC 
intervention was effective in increasing participants’ HCV knowledge; increasing overall 
intentions to abstain from drug use, and improving attitudes towards abstaining from drug 
use.  The intervention also was successful at encouraging participants to test for HCV.  
The intervention did not result in significant gains in HIV knowledge nor in intentions to 
practice safer sex. In addition, results also revealed a lack of congruence between self 
reported drug use and the urinalysis and arrest data.  Emergent themes from the focus 
group data validated findings from the survey data.  Overall, TITTC appears to have 
some positive effects on participants’ intentions to engage in HIV and HCV risk 
reduction behaviors.  Evaluators recommend that the program be lengthened and that 
facilitators spend more time on the areas where fewer gains were seen.  Given the 
preliminary success of the program, expanding TITTC to other drug courts throughout 
the state of Montana is advised.   
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Chapter I 
 
Introduction 
 
Drug court rose out of Dade County, Florida in 1989 as a response to jails becoming 
overcrowded with individuals on non-violent drug charges. The drug court model was the 
first attempt to rehabilitate drug offenders utilizing a combination of the criminal justice 
system, social services, counseling, and life training skills (Huddleston, Freeman-Wilson, 
& Boone, 2004). The purpose of drug courts is to reduce recidivism and substance abuse 
rates among nonviolent substance abusing offenders and “increase the offenders’ 
likelihood of successful habilitation through early, continuous, and intense judicially 
supervised treatment, mandatory periodic drug testing, community supervision and use of 
appropriate sanctions and other habilitation services” (Huddleston et al., 2004). The 
National Survey on Drug Use and Health estimated there were 19.9 million illicit drug 
users aged 12 and older (DPHHS, 2008), so it is not surprising widespread adoption of 
the drug court model has occurred throughout the United States and is appearing 
internationally as well.  As of December 31, 2007 there were 2,147 drug courts operating 
in the United States, and this number continues to grow every year (Huddleston, 
Marlowe, & Casebolt, 2008). Many new drug court models have specific population 
targets such as adults or juveniles only, families, universities, tribes or drunk driving 
(Huddleston et al., 2004).  
    Family drug treatment courts first appeared in Reno, Nevada in 1995. This 
system utilized the traditional drug court model, but narrowed the focus to drug abusing 
parents charged with child abuse or neglect, in a civil rather than criminal court system.  
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Family drug court was designed to address findings suggesting that 80% of child abuse 
cases involved parents who had a substance abuse problem (Huddleston et al., 2008).  
The ultimate goal is timely resolution of the child maltreatment cases for the benefit of 
children, families and society (Roche, 2008).  As of December 31, 2007 there were 301 
family drug courts in operation, and four of those were located in Montana (Huddleston 
et al., 2008). 
Yellowstone County Family Drug Treatment Court (YCFDTC) is one of the 
family drug court systems in Montana.  The focus of this study was on YCFDTC’s 
human immunodeficiency virus (HIV) and hepatitis C (HCV) prevention intervention 
Taking it to Treatment Court (TITTC) in Billings, MT.  Specifically, the study examined 
TITTC’s effectiveness to promote factors that enhance participants’ intentions to practice 
HIV and HCV risk reduction behaviors – in particular the practice of safer sex and 
abstinence from drug use.  
Injection drug use (IDU) is the most common route of exposure for HCV and 
second most common route for HIV (CDC: Basic Statistics, 2008; CDC: MTDPHHS, 
2008).  HIV is the virus that causes acquired immunodeficiency syndrome (AIDS) which 
impairs immune function, ultimately leading to death (CDC, 2006).  There are 
approximately 1.1 million people living with HIV/AIDS in the United States.  In 2006 
there were 56,300 new cases of HIV diagnosed (CDC, 2008).  Practicing unsafe sex, 
vaginally or anally, is the most common route of exposure for HIV infection.  Men who 
have sex with men (MSM) are the highest risk group for HIV (CDC: Basic Statistics, 
2008).  While injection drug use is not the most common route of exposure to HIV, it 
does contribute to infection rates indicating more prevention and awareness efforts are 
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needed within this population.  Injection drug use has accounted for 36% of all reported 
HIV cases in the US since the epidemic began (CDC, 2002).   
As of February 17, 2010, there were 955 reported cases of HIV in Montana since 
1985; of those reported cases, 445 are living cases.  Injection drug use accounts for 13% 
of the reported cases of HIV in Montana (MT-DPHHS, 2009).  In February 2009 there 
were 122 known living cases of HIV related to injection drug use in Montana, with 33 
percent, or 40 of those cases in Yellowstone County (MT-DPHHS, 2009).  
HIV positive people who use injection drugs frequently are co-infected with 
HCV.  Studies funded by the National Institute on Drug Abuse (2008) have found that 
within three years of injection drug use, most injection drug users will contract HCV, and 
upwards of 90% of HIV infected persons who use injection drugs may also be infected 
with HCV.  Hepatitis C (HCV) is a viral infection of the liver transmitted through 
contaminated blood which can lead to cirrhosis and liver cancer in chronic cases (CDC: 
Hepatitis C, 2008).   HCV is the most common chronic blood borne infection in the 
United States, and the most common route of exposure is injection drug use (Shepard, 
Finelli, & Alter, 2005).  The United States is estimated to have 3.2 million people 
chronically infected with HCV, with an estimated 30,000 new cases each year (CDC: 
Hepatitis C, 2008).  Of those new cases, approximately 68% are attributable to IDU 
(Shepard et al., 2005).   
Prevention strategies remain crucial to slow the spread of HIV and HCV infection 
amongst persons who use injection drugs since there is no cure or vaccination for either 
virus (CDC, 2006; WHO 2000).  Prevention strategies focus on education and harm 
reduction methods such as community outreach, methadone treatment, needle exchange, 
4 
 
and in-patient or out-patient abstinence programs (Coyle, Needle, & Normand, 1998). 
Community outreach strategies, such as face-to-face communication; HIV awareness, 
prevention, and available services; condom distribution; bleach kit distribution for 
cleaning injection equipment; information on available drug treatment options within the 
community; and HIV testing and confidential risk assessments, have been identified as 
one of the top three prevention strategies for reducing incidence of HIV among IDUs 
(Coyle et al., 1998). Providing sterile injection equipment and providing education on 
safer injection practices remain the primary methods to reduce HCV incidence (Edlin, 
2002).  While disease transmission rates have gone down in the presence of prevention 
efforts, HCV rates remain high compared to HIV rates amongst persons who use 
injection drugs.  Hepatitis C transmission is approximately ten times more efficient than 
HIV (Edlin et al., 2005) indicating prevention efforts need to be directed at more than just 
using sterile syringes.   
Taking it to Treatment Court (TITTC) is the only intervention program within the 
YCFDTC system to offer clients information on HIV and HCV risk reduction behaviors.   
This intervention also provides YCFDTC participants the opportunity to enhance their 
education and awareness of HIV and HCV, build a support system, and receive one-on-
one mentoring.   After completion of the six hour course, a graduation ceremony is held 
one week later, open to friends and family.  Participants are given the opportunity to 
discuss what they learned from TITTC.  The final stage of TITTC consists of two 
individual follow up sessions with the group facilitator over a two month period where 
participants can seek more individualized care and referrals as needed.    Participants of 
TITTC are encouraged to take advantage of the follow up services upon release from the 
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YCFDTC.  Some of these services include family support, job and housing referrals, 
street outreach, further HIV/HCV counseling, parole planning, and harm reduction 
counseling (Roche, 2008).   Follow-up services are coordinated by the outreach workers 
who facilitate TITTC. 
 
Purpose of the Study 
The purpose of this study was to evaluate the HIV/HCV prevention intervention, Taking 
it to Treatment Court. This evaluation examined whether the program (1) increased 
participants’ knowledge about HIV/HCV risk reduction behaviors and (2) if their 
attitudes and beliefs about safer sex and drug use were affected.  The findings from this 
study will be used by the Montana Department of Public Health and Human Services, 
The Yellowstone County Family Drug Treatment Court, and the Montana HIV 
Prevention Community Planning Group to determine the effectiveness of TITTC.  If 
found effective at increasing participants’ knowledge about HIV and HCV and their 
intentions to change risk behaviors associated with HIV and HCV, TITTC may be 
expanded to all family drug treatment courts in Montana. 
 
Statement of the Problem 
Injection Drug Use (IDU) is the leading risk factor for HCV in the United States 
today (CDC: Hepatitis C, 2008).  As of December 31, 2008 there were 9,593 known 
cases of HCV in Montana.  It is estimated 20 to 40 percent of those cases are related to 
IDU, or 1,919 to 3,837 cases respectively (Baus: CDC, 2009). The use of injection drugs 
is a major risk factor for HIV as well.  In February 2009 there were 122 known living 
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cases of HIV related to injection drug use in Montana with 33 percent, or 40 of those 
cases, in Yellowstone County (MT-DPHHS 2009).  Preliminary data from the Montana 
Department of Public Health and Human Services (2008) estimates 93 known living 
cases of HIV and HCV co-infection in Montana with injection drug use as the primary 
risk factor.   
 
Research Questions 
Research questions for this study focused on the effect Taking it to Treatment Court had 
on YCFDTC clients’ knowledge, attitudes, beliefs, subjective norm, and control factors 
pertaining to HIV and HCV risk reduction behaviors.  For the purpose of this study, risk 
reduction behaviors were defined as abstinence from drug use and safer sex practices 
through condom use.  The questions were as follows: 
 
Hypothesis 1 
Intervention participants will demonstrate a significant gain in mean knowledge scores on 
The HIV Knowledge Questionnaire between pretest and a two week post test.  
1a: These gains will be maintained at a three month follow-up post test.  
 
Hypothesis 2 
Intervention participants will demonstrate a significant gain in mean knowledge scores on 
The HCV Knowledge Questionnaire between pretest and a two week follow-up post test.  
2a: These gains will be maintained at a three month follow-up post test.  
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Hypothesis 3 
Intervention participants will demonstrate significant gains in intention to practice safer 
sex as demonstrated by scores on the Theory of Planned Behavior Questionnaire between 
pretest and a two week post test in the following areas: 
a) positive attitude toward condom use 
b) positive subjective norm toward condom use 
c) positive control beliefs regarding condom use 
3a:  These gains will be maintained or further improve at the three month follow-up post 
test. 
 
Hypothesis 4  
 Intervention participants will demonstrate significant gains in intention to abstain from 
drug use as demonstrated by scores on the Theory of Planned Behavior Questionnaire 
between pretest and a two week follow-up posttest in the following areas: 
a) positive attitude toward abstaining from drug use 
b) positive subjective norm toward abstaining from drug use  
c) positive control beliefs regarding abstinence from drug use 
4a:  These gains will be maintained or further improve at the three month follow-up -post 
test.   
               
Research Sub-Questions 
1. What are the perceptions of individuals who participated in the HIV/HCV 
prevention  intervention,  Taking it to Treatment Court, in regards to: 
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a. the extent to which the intervention did or did not empower them to 
engage in HIV/HCV risk reduction behaviors?  
b. aspects of the HIV/HCV intervention that were influential at encouraging 
them to engage in risk reduction behaviors?  
2. How closely does self-reported drug use correlate with urinalysis and arrest     
             records.  
 
Delimitations 
The delimitations of the study were as follows: 
1. The study was delimited to persons enrolled in the Yellowstone County 
Family Drug Treatment Court in Billings, Montana from August 2009 to April 
2010. 
2. Data were collected using a written questionnaire, focus groups, and court 
provided urinalysis data and arrest records. 
3. Data collected with the written questionnaire and focus groups were restricted 
to participants’ self report.  
4. The subjects for this study were voluntary participants who self selected 
themselves. 
5. The data collected was delimited to the Taking it to Treatment Court 
curriculum which is a small program within the larger court system.  
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Limitations 
The limitations for this study were as follows: 
1. Information gathered in this study from the written questionnaire was limited 
to the voluntary action of the participants completing the questionnaire. 
2. Information gathered in this study from focus groups was limited to 
participants being able to attend the meetings and openly share their personal 
information.  
3. All of the information collected from the written questionnaire and focus 
groups all based on self-reporting which can produce socially desirable 
answers that are not honest or accurate. 
4. The study was limited by the small population of participants in the 
intervention.  
 
Definitions of Terms 
Child Abuse and Neglect:  Any recent act or failure to act on the part of a parent or 
caretaker which results in death, serious physical or emotional harm, sexual abuse 
or exploitation, or an act or failure to act which presents an imminent risk of 
serious harm (US: DHHS, 2009). 
HCV:  Hepatitis C, viral hepatitis contracted only through transmission of infected blood 
and can lead to cirrhosis of the liver and/or liver cancer (CDC:  Hepatitis C, 
2008).     
HIV:  Human Immunodeficiency Virus, the virus that causes AIDS (CDC, 2006).   
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Incidence:  A measure of the frequency of occurrence of a disease or health problem in a 
population based on the number of new cases over a given period of time (Green 
and Krueter, 2005). 
IDU:  Injection drug use 
Prevalence: A measure of the extent of a disease or health problem in a population based 
on the number of cases (old and new) existing in the population at a given time 
(Green and Krueter, 2005).  
Recidivism:  habitual relapse into crime and drug use (Huddleston, Marlowe, & 
Casebolt, 2008). 
Risk Reduction Behaviors:  behaviors that lead to abstinence from drug use and 
practicing safer sex (Semaan, Des Jarlais, & Malow, 2006)  
Safe sex:  the use of condoms while engaging in sexual behavior to reduce the risk of 
sexually transmitted infections and HIV (CDC, 2010)  
Seroconversion:  The presence of HIV or HCV antibodies in previously seronegative 
individuals, or becoming positive for HIV or HCV (Fuller, Ompad, Galea, Wu, 
Koblin, & Vlahov, 2004). 
TITTC:  Taking it to Treatment Court 
YCFDTC:  Yellowstone County Family Drug Treatment Court  
11 
 
CHAPTER II 
Review of Literature 
 
Traditionally there have been three options for the treatment of substance abuse: 
incarceration, abstinence based programs, and harm reduction (WHO, 2006). 
Incarceration involves punishing and removing illicit drug users from society using the 
criminal justice system (Cusick, 2005). Abstinence based programs involve treating drug 
use as a disease or illness through long-term hospitalization, methadone maintenance 
programs, outpatient, and self help groups (WHO, 2006). Harm reduction interventions 
suggest stopping the use of illicit drugs should not always be the top priority, but rather 
attention should be focused on introducing harm reduction techniques to minimize the 
risks associated with the injection of illicit drugs, like HIV or HCV contraction (Cusick, 
2005).  A fourth treatment option emerged in 1989 called drug court.  Drug court is a 
collaborative treatment option with participation from social services, counselors, judges, 
and the judicial system (Huddleston, Marlowe, & Casebolt, 2008).  Drug court seeks to 
reduce the reliance on incarceration of non-violent drug abusers and fully rehabilitate the 
individual by treating the addiction through abstinence based program options 
(Huddleston et al., 2008).   
This chapter is an overview of the current literature on drug courts as a treatment 
option for drug users, the intervention strategies available for reducing HIV and HCV 
incidence among drug users, and the intervention Taking it to Treatment Court that will 
be evaluated in this study.   The chapter is divided into six sections:  1) Drug Courts, 2) 
Yellowstone County Family Drug Treatment Court, 3) Description of the intervention, 
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4)HIV:  injection drug use and prevention strategies, 5) HCV:  injection drug use and 
prevention strategies, and 6) Theory of Planned Behavior.  
 
Drug Courts 
The first drug court began operation in 1989 in Dade County, Florida as a response to 
jails that were overcrowded with individuals on non-violent drug charges (Huddleston, 
Freeman-Wilson, & Boone, 2004).  The drug court model was the first attempt to 
rehabilitate non-violent drug offenders utilizing the criminal justice system, social 
services, counseling, and life skills training. The purpose of drug courts is to reduce 
recidivism and substance abuse rates among nonviolent substance abusing offenders and 
“increase the offenders likelihood of successful habilitation through early, continuous, 
and intense judicially supervised treatment, mandatory periodic drug testing, community 
supervision and use of appropriate sanctions and other habilitation services” (Huddleston 
et al., 2004).  
The Arrestee Drug Abuse Monitoring study (2000) found between one-fourth and 
one-half of all adult males arrested, and one-half of all females arrested were at risk for 
drug dependence.  The National Survey on Drug Use and Health estimated there were 
19.9 million illicit drug users aged 12 and older (DPHHS, 2008).  The widespread 
adoption of the drug court model is an attempt to reduce drug use rates in the United 
States, and is gaining international popularity as well.  As of December 31, 2007 there 
were 2,147 drug courts operating in the United States, and this number has grown every 
year since 1989 (Huddleston, Marlowe, Casebolt, 2008).  Much public and private 
funding has come forth to support drug courts over the years as well.  The US General 
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Accounting Office estimated in 1997 that from 1989 to 1997, over $80 million in federal 
funding went to planning, implementing, improving, and evaluating drug courts across 
the United States (Wilson, Mitchell, & Mackenzie, 2006).   
The time a person spends in drug courts varies, but is generally one year to 
eighteen months.  Individuals have regularly scheduled hearings with a judge to discuss 
their progress in the program.  They also have scheduled urinalysis testing to monitor for 
drug use (Huddleston et al., 2008).  Drug court is a system of rewards and sanctions.  
Rewards range from verbal praise to dropping the criminal charges upon successful 
completion of drug court.  Sanctions can range from verbal reprimands to incarceration.    
Drug courts will also assist individuals with finding jobs or a home, reuniting families, 
and improving social and life skills (Huddleston et al, 2008). 
Family treatment drug courts (FTDC) operate on the same premise as adult drug 
court: to reduce recidivism of drug abusers (Worcel, Furrer, Green, Burrus, & Finigan, 
2008).  The differences come from who is targeted and the ultimate goal.  Clients served 
in FTDCs are parents with substance abuse problems who are charged with child neglect 
or abuse.  The goal is to treat the parents’ addictions and provide a safe permanent home 
for the child/ren, whether through reunification with the parent(s) or adoption.  The 
ultimate goal for parents in FTDC is not only avoiding jail time and dropped felony 
charges, but reunification with their children and permanent custody (Worcel et al., 
2008).  While reunification is preferred, it is not always in the best interest of the 
child/ren.   
As of December 31, 2007 there were 301 operating FTDC in the United States 
(Huddleston et al., 2008).  The first FTDC began operation in Reno, Nevada in 1995 
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(Roche, 2008).  These courts seek to break the cycle of addiction that has been correlated 
with children of addicted parents.  Children of addicted parents have a two to nine 
percent increased risk for developing substance abuse problems later in life (Kumpfer and 
Johnson, 2007).  It is estimated that 25% of children, or 19 million, in the United States 
under the age of 17 have a parent who is an alcoholic, and 12.7% of children, or 9.2 
million, have parents with a chemical dependency (Kumpfer and Johnson, 2007).  Having 
a parent who uses alcohol or drugs increases the likelihood for the child to use later in 
life.  Families that drink alcohol raise youth that drink alcohol 82% of the time, compared 
to families that abstain from alcohol use who raise children that abstained 72% of the 
time (Kandel et al., cited in Johnson and Leff, 1999).  A national survey conducted by the 
National Center on Child Abuse and Neglect (2003), found that children of substance 
abusing parents are three times more likely to be abused and four times more likely to be 
neglected than children of parents who do not abuse alcohol and/or other drugs 
(Gaudiosi, 2003).  
Like drug court, family treatment drug courts require frequent court hearings 
(often weekly), intensive judicial monitoring, provisions of substance abuse treatment, 
drug screening, and rewards and sanctions based on progress through the court system 
(Huddleston et al., 2008).  One major difference between the court models are the 
populations served; adult drug courts are predominantly male clients, while FTDC are 
approximately 85% female (Worcel et al., 2007). Another difference is the goal of the 
clients being served, as mentioned earlier.  Drug court participants final outcome is 
avoiding jail or prison time and having felony drug charges dropped.  Family drug court 
clients’ final outcome is reunification with their children, and hopefully full permanent 
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custody (Huddleston et al., 2008).  Parents in FTDC often times have many issues outside 
of addiction that need addressing before reunification can occur.  Parents must find 
employment, housing, and demonstrate new parental skills before a child will be 
returned.  Successful treatment of the addicted parent has been positively correlated to the 
likelihood of reunification with children (Worcel et al., 2008). 
Research on whether FTDC is effective is limited.  However, preliminary studies 
are finding promising results.  One retrospective study compared participants of a FTDC 
to clients served through a more traditional child welfare system (Green, Furrer, Worcel, 
Burrus, & Finigan, 2007).   The results found parents were more likely to enter treatment, 
and entered treatment more quickly, stayed in treatment longer, and were more likely to 
complete treatment if they were enrolled in FTDC than the child welfare system.  The 
parents in FTDC were also reunified with their children more often than parents in the 
child welfare program (Green et al., 2007).  In a prospective follow up study, Worcel et 
al., (2008) also found that women who entered FTDC were more likely to enter 
treatment, entered treatment faster, stayed in treatment twice as long, and were twice as 
likely to complete treatment as the comparison group.  The comparison group was 
comprised of women who had qualified for FTDC, but were unable to participate. 
Participants of FTDC were also twice as likely to be reunified with their children as the 
comparison group (Worcel et al., 2008). While preliminary data is showing positive 
results for FTDC, more information in needed on why reunification is more prevalent for 
the drug court model.  Studies would benefit from an examination of the various 
components of FTDC to determine which aspects reduce recidivism and increase the 
likelihood of parent/child reunification.    
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Yellowstone County Family Drug Treatment Court 
Yellowstone County Family Drug Treatment Court began operating in June 2001 to serve 
parents with substance abuse problems involved in the Child Welfare System in 
Yellowstone County, Montana (For a complete list of participant criteria see Appendix 
C) (Roche, 2008).  Yellowstone County is located in south central Montana with an 
estimated population of 139,936 (US Census Bureau, 2007).  The mission of YCFDTC is 
to reduce the rate of substance use among parents in the Yellowstone County who are 
involved with the Child Welfare System, reunify parents with their children (when 
appropriate), and to reduce the frequency of future drug offenses, criminal offenses, and 
child maltreatment reports for YCFDTC participants (Roche 2008). 
The goals of YCFDTC are to: 
1. Increase the court’s influence over child abuse and neglect cases; 
2. Promote children’s safety by reducing substance abuse and subsequent child 
abuse and neglect among participants; 
3. Establish permanency for children in the Child Welfare System, reunifying 
children with parents whenever possible; 
4. Address the family’s social and economic needs by identifying the needs and 
strengths of the family that will aid them in leading a law abiding and substance 
free life; 
5. Strengthen the capacity of families to promote structure, guidance, and nurturance 
for their children;  
6. Increase participants overall physical and mental health status; and  
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7. Develop and evaluate an operational model for family drug courts to be replicated 
in other jurisdictions (Roche 2008). 
To date YCFTDC has served 97 adults and 167 children.  The minimum number of 
months an individual must remain in the YCFDTC is twelve, but on average participants 
take sixteen months to graduate (Roche, 2008).  As of November 11, 2008, 31 of the 97 
participants had graduated from YCFDTC, 26 participants were terminated after being in 
YCFDTC for more than 60 days, 15 individuals were terminated within the first 60 days 
of YCFDTC, one individual had their case transferred to Tribal Jurisdiction, 20 clients 
are still active in the YCFDTC, four opted to return to the regular drug treatment after 60 
days, and four opted for regular drug treatment within the first 60 days of YCFDTC 
(Roche, 2008). The total number of participants is less than 97 because three of the 
participants graduated twice from YCFDTC and one of the individuals terminated after 
60 days was the same individual whose case was transferred to Tribal Jurisdiction 
(Roche, 2008).  Graduation is marked by reunification of the client with their child/ren 
(Roche, 2008). 
 In comparison to traditional drug treatment programs, the YCFDTC has been 
found to have a higher success rate of parent/child reunification.  In Roche’s (2008) 
evaluation of the YCFDTC, a comparison study was mentioned which examined 
reunification rates between YCFDTC and a control population of parents with child 
neglect and/or abuse charges related to substance abuse.  Results found that permanency 
of children was established in 74.5% of YCFDTC participants compared to 64% in the 
control group.  Forty nine percent of parental rights were terminated in the control group, 
compared to 3.7% in the YCFTDC group.  Finally, no parental rights were relinquished 
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in the control group compared to 27.9% relinquished in the YCFTDC group (Roche, 
2008).   Further studies comparing YCFDTC to other similar treatment models could 
reinforce the findings from this study to build a stronger case for YCFDTC and other 
FTDC. 
 
Description of the Intervention 
Taking it to Treatment Court is a pilot intervention currently implemented as one of the 
many aspects of the Yellowstone County Family Drug Treatment Court (YCFDTC) in 
Billings, MT.   It is a six hour group level intervention with a follow-up component 
consisting of phone calls.  The primary purpose of the intervention is to educate, 
motivate, and support the practice of HIV and HCV risk reduction behaviors among 
participants in YCFDTC.   
Taking it to Treatment Court is based on Fishbein’s Theory of Planned Behavior 
(TPB).  This behavior change model distinguishes between attitudes toward a behavior 
and attitudes towards the outcomes or goals of a behavior.  This model demonstrates that 
behavior can better be predicted based on the attitude toward the behavior, than the 
attitude toward the outcome (Montano, Kasprzyk, & Taplin, 1997).  For example, a 
person’s attitude toward safer sex and abstinence from drug use is a better predictor of 
those behaviors than a person’s attitude towards the risk of contracting HIV or HCV 
from not practicing safer sex or abstaining from drugs.   
Furthermore, Fishbein asserts the best way to predict a person’s behavior is by 
ascertaining that person’s behavioral intention (Montano, et al, 1997).  According to this 
model, there are three direct determinants of behavioral intention:   
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 Attitude toward Performing the Behavior: attitude is determined by the individual’s 
beliefs about the outcome of the behavior and by how much the individual values that 
outcome. 
 Subjective Norm: subjective norm is determined by whether or not important or 
significant people approve or disapprove of the behavior, weighted by the 
individual’s motivation to comply with those significant people.   
 Perceived Behavioral Control:  behavioral control is determined by the presence of 
facilitators and barriers to behavioral performance, weighted by the perceived power 
of each factor to facilitate or inhibit the behavior.   
 Each of the three determinants of behavioral intention is addressed by the 
intervention TITTC.  The following is a description of intervention components designed 
to influence the model’s three main constructs.   
Elements that Influence Attitudes:  
 Provide information about HIV/HCV transmission. 
 Increase perceptions of risk related to HIV/HCV in Montana. 
 Address negative attitudes regarding condom use and abstinence from drugs. 
 Facilitate the development of personal goals related to HIV/HCV prevention. 
 Discuss the relationship between personal goals and behaviors related to those 
goals. 
Elements that Influence the Participants Subjective Norm:  
 Increase awareness of social norms related to safer sex and drug use. 
 Provide support and a safe environment for discussion of social norms related to 
safer sex and drug use. 
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 Provide positive role models whose lives demonstrate the successful attainment of 
the desired behaviors. 
Elements that Influence Perceived Behavioral Control :   
 Develop risk reduction goals and steps for achieving those goals. 
 Practice decision-making or problem-solving skills related to barriers to 
practicing safer sex and/or abstaining from drug abuse. 
 Identify and develop methods for managing triggers for engaging in risky sex 
behaviors and/or drug use. 
Taking it to Treatment Court also incorporates some of the qualities of effective HIV 
prevention interventions identified by Lyles et al. (2007) in a meta-analysis of 100 
behavioral interventions.  The qualities of effective interventions identified were:   
 The intervention is structured based on behavioral theory. 
 The intervention is facilitated by an individual that is indigenous to the target 
population. 
 The intervention includes technical, personal and interpersonal skill-building 
components. 
 The intervention utilizes a variety of delivery methods:  
 discussion, 
 demonstration, 
 lecture/instruction, and 
 role play. 
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HIV and Injection Drug Use 
The human immunodeficiency virus (HIV) is the virus that causes acquired 
immunodeficiency syndrome (AIDS) (CDC, 2006).  HIV lives within the infected 
individual’s immune system by hosting in the white blood cells, or CD4+ lymphocytes.  
HIV weakens the individual’s immune system over time leaving them more susceptible 
to other illnesses and infections (NIDA, 2008).  Contact with HIV infected blood or other 
bodily fluid can transmit the virus.  Practicing unsafe sex, vaginally or anally, and 
injection drug use are the two highest risk factors for exposure to HIV (CDC: Basic 
Statistics, 2008).  The use of non-injection drugs and alcohol can impair judgment and 
result in risky sexual behavior, such as not wearing a condom, increasing the possibility 
of exposure to HIV as well.  Although IDU is not the most common route of exposure for 
HIV, IDU continues to expose and infect individuals with the virus indicating more 
prevention and awareness efforts are needed (CDC: Basic Statistics, 2008). 
The first case of HIV among persons who use injection drugs was in New York in 
1981.  The discovery of HIV among persons who use injection drugs did not gain much 
national attention immediately, as it was considered to be a geographically isolated 
incidence of HIV with low prevalence through 1984; only 1,353 cases of HIV were 
reported up to this point (Des Jarlais, Friedman, & Ward, 1993).  More sophisticated tests 
for the presence of HIV/AIDS antibodies were developed and people were getting testing 
around the world.  Results from individuals’ tests revealed HIV was no longer a small 
New York issue (Des Jarlais et al., 1993).  HIV test results showed half the persons who 
used injection drugs in New York and northern New Jersey’s were infected with HIV, 
30% of Amsterdam’s IDU population were infected, and 50% of Edinburgh and parts of 
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Italy’s IDU population were infected as well (Des Jarlais, et al., 1993).   HIV was also 
being transmitted to non-injecting sex partners and perinatally from infected mothers.   
During the 1980s IDU was considered the most common route of exposure to HIV/AIDS 
(Des Jarlais et al., 1993).   
There are approximately 1.1 million people living with HIV in the United States.  In 
2006 there were 56,300 new cases of HIV diagnosed (CDC: Basic Statistics, 2008).  
Compared with the rest of the United States, Montana has a low incidence of HIV, 21.1 
cases per 100,000 and 1.7 cases per 100,000, respectively (MT-DPHHS, 2009).  As of 
February 17, 2010, there were 955 reported cases of HIV in Montana since 1985; of those 
reported cases, 445 are living cases.  During 2000 to 2008 there was anywhere from 16 to 
27 new cases of HIV reported in Montana each year (MT-DPHHS, 2009).  In 2008, 22 
cases of HIV were reported and five of those cases were related to injection drug use.  In 
total, 13% of the reported cases in Montana are related to injection drug use (MT-
DPHHS, 2009).  In February 2009 there were 122 known living cases of HIV related to 
injection drug use in Montana, with 33 percent, or 40 of those cases in Yellowstone 
County (MT-DPHHS, 2009).   
Many factors contribute to the rapid spread of HIV among IDUs.  The factors go 
beyond the sharing of injection equipment.  Des Jarlais and Semaan (2008) explain these 
factors as: 
1. Lack of information about HIV/AIDS in the local IDU population. 
2. Restricted access to sterile needles and syringes for drug users.  The restrictions 
may be related to laws, such as requiring prescriptions for the sale of syringes and 
drug paraphernalia, or from law enforcement practices, such as stationing police 
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near syringe exchange programs or arresting drug users for drug residue in a used 
syringe. 
3. Situations that create rapid risk-partner change where IDUs may share needles 
and syringes with many IDUs in a short time period.  Examples include “shooting 
galleries” in which a single needle and syringe are rented out to multiple users; 
“dealer’s works,” where a drug dealer may lend the same needle and syringe to 
many sequential customers; and “hit doctors,” who may use the same needle and 
syringe to inject many clients who may have trouble injecting themselves. 
4. People recently infected with HIV tend to be very infectious. 
 Another common practice among persons who use injection drugs is to pool 
resources to purchase drugs.  Pooling resources to obtain drugs increases the likelihood of 
sharing injecting equipment and backloading.  Backloading is the process of dividing 
drugs using one syringe to fill the drug solution into the backs of other syringes.  If the 
parent syringe is not sterilized before distribution and contaminated with HIV, the 
opportunity for HIV infection increases (Hahn, Page-Shafer, Lum, Bourgois, Stein, 
Evans, Busch, Tobler, Phelps, & Moss 2002).     
 
Prevention Strategies 
The human immunodeficiency virus has no cure.  There are several treatment options 
available to slow down the progression of the disease which involves taking antiretroviral 
drugs (CDC, 2009).  The use of antiretroviral drugs reduces the plasma viral load in the 
bloodstream to undetectable levels making an individual less infectious (CDC, 2009).  
While antiretroviral therapy is not a cure, there have been advancements in these over the 
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years.  Since the introduction of combination antiretroviral therapy in 1996, the life 
expectancy for person’s living with HIV have improved (Schackman, Gebok, Walensky, 
Losina, Muccio, Sax, Weinstein, Seage, Moore, & Freedberg, 2006).  With proper use of 
combination antiretroviral drugs, life expectancy from the time of diagnosis is 24.5 years.  
It was estimated in 2006 the lifetime cost to treat HIV for that amount of time was 
$618,900 (Schackman et al., 2006).   
As funding continually goes to finding a cure and vaccination for HIV, prevention 
strategies remain crucial in slowing the spread of this disease (NIDA, 2008).  
Intervention strategies to reduce the incidence of HIV among persons who use injection 
drugs have evolved over time.  Some intervention strategies include community outreach, 
methadone treatment, needle exchange, and in-patient or out-patient abstinence programs 
(Coyle, Needle, & Normand, 1998). 
One of the earliest primary prevention strategies was community outreach, relying 
on peers and indigenous members of the IDU community to educate out-of-treatment 
persons who use injection drugs on the dangers of unsafe drug and sex practices using 
culturally appropriate language and information.  Outreach has been identified as one of 
the top three prevention strategies for reducing incidence of HIV among IDUs (Coyle et 
al., 1998).  Strategies for community outreach are based on harm reduction principles like 
face to face communication; HIV awareness, prevention, and available services; condom 
distribution; bleach kit distribution for cleaning injection equipment; information on 
available drug treatment options within the community; and HIV testing and confidential 
risk assessments.   Coyle et al.’s (1998) meta-analysis on the effectiveness of community 
based HIV interventions for persons who use injection drugs found that between 24% and 
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31% of outreach participants reported stopping injecting in the past 30 days.   Participants 
that did not stop injecting reported using less in the past 30 days, from 73 injections per 
month to 45 injections per month (Coyle et al., 1998).   
One study assessed the risk of sexual transmissions for HIV amongst persons who 
use injection drugs compared to persons who use non-injection drugs (Booth, 
Kwiatkowski, & Chitwood, 2000).  Current drug users, defined as using in the past 30 
days, and were out-of-treatment injectors and crack cocaine smokers, were recruited from 
22 cities (n=26,982).  The cities were part of a National Institute on Drug Abuse 
Cooperative Agreement which was evaluating the effectiveness of community based 
intervention strategies to reduce risk behaviors for HIV among persons who use injection 
drugs (Booth et al., 2000).   Participants were interviewed and asked questions about their 
sexual risk behaviors in the 30 days prior.  Results indicated 28 percent reported having 
sex with two or more individuals, 23 percent had a partner who used injection drugs, 24 
percent exchanged sex for drugs or money, and 80 percent reported not using a condom 
during sex (Booth et al., 2000).  Booth et al. (2000) conclude that addressing condom use 
in prevention strategies for persons who use drugs remains crucial, as sexual transmission 
remains a primary route of HIV exposure.        
 
HCV and Injection Drug Use 
Hepatitis C (HCV) is a viral infection of the liver transmitted through contaminated blood 
and can lead to cirrhosis and liver cancer in chronic cases (CDC: Hepatitis, 2008).  Prior 
to its causative agents discovery in 1989, it was called parenterally transmitted non A and 
non B hepatitis (WHO, 2000).   It is considered the leading cause of chronic liver disease 
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and liver transplants in the world.  Approximately 80% of all HCV cases become chronic, 
with 10-20% resulting in cirrhosis and 1-5% resulting in liver cancer (WHO, 2000).  
HCV is also the most common chronic blood borne infection in the United States (CDC: 
Hepatitis, 2008).  HCV can be transmitted through blood transfusions from unscreened 
donors, injection drug use, unsafe therapeutic injections and health care related 
procedures (Shepard, Finelli, & Alter, 2005).  It is estimated globally that 170 million 
people are infected with HCV, or 3% of the total global population, with 3 to 4 million 
new cases each year (WHO, 2000).  The incubation period for HCV can be anywhere 
from 15 to 150 days, with mild to no symptoms for years.  The most common symptoms 
include jaundice and fatigue (CDC: MTDPHHS, 2008). 
Prior to 1990, blood transfusions were the most common route of exposure to 
HCV in the United States (CDC: Hepatitis, 2008).  Upon HCV’s discovery, blood was 
screened more thoroughly, and the current risk for HCV from blood transfusions in the 
United States is marginal.  Injection drug use is now the most common route of exposure 
to HCV in the United States and other developed nations (Edlin 2002; CDC: Hepatitis, 
2008; WHO, 2000; Shepard et al., 2005).  The United States is estimated to have 3.2 
million people chronically infected with HCV, with an estimated 30,000 new cases each 
year (CDC: Hepatitis, 2008).  Of those new cases, approximately 68% are attributable to 
IDU (Shepard et al., 2005).  Studies funded by the National Institute on Drug Abuse 
(2008) have found that within three years of injection drug use, most IDUs will contract 
HCV, and 90% of HIV infected IDUs may also be infected with HCV. 
As of December 31, 2008 there were 9,593 known cases of HCV in Montana 
(Baus; CDC, 2009).  Approximately 20-40 percent of those cases are related to injection 
27 
 
drug use, or 1,919-3,837 cases respectively (Baus; CDC, 2009). In 2008 there were 943 
cases of HCV, chronic and acute, reported in Montana and 218 of those cases were in 
Yellowstone County.  The overall rate for HCV in Montana is 97 cases/100,000 
population (Baus; CDC, 2009). The number of individuals diagnosed with HCV under 
the age of 25 was relatively high in Montana, 65 cases per 100,000, most likely indicating 
injection drug use (MTDPHHS, 2009) and a need for earlier prevention efforts.    
HCV prevalence in persons who use injection drugs range from 80-90%, and 
estimates for the number of people who inject drugs is one to 1.5 million (Edlin, Kresina, 
Raymond, Carden, Gourevitch, Rich, Cheever, & Cargill 2005).  Intervention programs 
targeted at reducing needle sharing for HIV prevention over the past 15 years were 
effective, and now fewer IDUs share syringes.  However, sharing injection equipment 
remains a common practice and the reduction in needle sharing has not reduced the 
incidence of HCV as effectively as HIV.  Hahn et al. (2002) recruited persons who use 
injection drugs and tested for HCV seroprevalence.  The persons who use injection drugs 
that tested negative for HCV were asked to return for a second screening to monitor for 
seroconversion.  Forty-eight participants seroconverted to HCV for a seroconversion rate 
of 25.1/100 person years.  Sixty-seven percent of the participants self-reported borrowing 
a needle or syringe and 85% had ever shared drug preparation equipment (Hahn et al., 
2002).   
The transmission of HCV is estimated to be 10 times more efficient than HIV, 
and is generally a result of not only sharing syringes, but also sharing injection 
equipment, like cookers (bottle caps, spoons, or any other container to dissolve drugs), 
and cottons, i.e. filters to remove particulate matter while drawing up the drug solution 
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into the syringe (Edlin et al, 2005).  Backloading, like HIV, is another transmission route 
for HCV (Hahn et al., 2002).  Some other risk factors include pooling money together to 
buy drugs, exchanging drugs for sex, and spending time in jail (Hahn et al., 2002).   
 
Prevention Strategies 
There is no vaccination or established cure for HCV, so prevention methods are crucial in 
reducing HCV incidence (WHO, 2000; Edlin, 2005).  Two antiviral drugs are prescribed 
for HCV, interferon and ribavirin.  Costs for these drugs remain high and the 
effectiveness is low for chronic HCV seroprevalence.  Interferon prescribed alone is 
effective in 10-20% of patients.  Ribavirin is ineffective on its own, but in combination 
with interferon they are effective in 30-50% of patients (WHO, 2000).  Approximately 
20% of new HCV cases reverse on their own without any treatment, but it is unknown 
why this occurs (Edlin, 2002).  If detected early, HCV treatments can reverse diagnosis if 
the virus is still in acute stages (Edlin et al. 2005).  Given the minimal success of antiviral 
drugs in chronic cases, primary and secondary prevention strategies remain critical in 
preventing the spread of HCV.  Most new infections in the US are amongst persons who 
use injection drugs, and so “developing, testing, and implementing effective prevention 
and treatment strategies for persons who inject drugs” is the primary way to control HCV 
(Edlin, 2002, p. s210).   
Prevention efforts to slow the spread of HCV amongst persons who use injection 
drugs have coincided with HIV prevention efforts (Wright and Thompkins, 2006).  Like 
HIV, education is needed to inform persons who inject drugs of the dangers of sharing 
needles and other injection equipment in regards to HCV exposure (Edlin, 2002).  
29 
 
Providing sterile injection equipment and providing education on safer injection practices 
remains the primary methods to reduce HCV incidence (Edlin, 2002).  Edlin (2002) 
suggests community based HCV prevention programs are needed as a means to provide 
outreach, counseling and testing, education on safer injection practices, and link 
individuals who are positive for HCV to medical care.       
The same prevention efforts used to prevent the spread of HIV have not been as 
effective at reducing the spread of HCV.  A meta-analysis (Wright and Tompkins, 2006) 
on the effectiveness of primary prevention interventions for HCV amongst persons who 
use injection drugs found that needle exchange programs reduce the incidence of HCV, 
though prevalence remains high, methadone maintenance programs marginally affected 
the HCV infection rate, and limited evidence supports the efficacy of behavioral 
interventions, bleach disinfectants, or drug consumption rooms.  Given HCV 
transmission is approximately ten times more efficient than HIV (Edlin et al, 2005); 
efforts need to be directed at more than just using sterile syringes.  Wright and Tompkins 
(2006) cited a study conducted in the US which found some evidence that sharing 
“cookers”, or spoons and/or metal containers to prepare and heat the drugs, presents a 
greater risk for spreading HCV than sharing cotton filters or water.    
    
Theory of Planned Behavior 
The Theory of Planned Behavior (TPB) was developed by Ajzen as an extension of the 
Theory of Reasoned Action (TRA).  The TRA was developed by Fishbein and introduced 
in 1967 (Montano, Kasprzyk, & Taplin, 1997).  Measures of attitude and social 
normative perceptions are determined to predict behavioral intention which in turn 
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predicts behavior according to the TRA.   An individual’s behavioral intentions are based 
on: 
 attitudes toward performing the behavior and  
 subjective norm associated with the behavior (Montano et al., 1997).    
Attitudes toward the behavior are based on: 
 behavioral beliefs toward the action and  
 an evaluation of the behavioral outcomes associated with action (Montano et al., 
1997).   
Subjective norm is based on normative beliefs:   
 and whether or not significant others approve of the behavior, and  
 the motivation to comply with significant others beliefs on performing or 
abstaining from the behavior (Montano et al., 1997).   
The TPB added a construct examining how perceived control influences behavioral 
intention as well.  The perceived control is based on control beliefs concerned with:  
 resource availability for and obstacles to performing the behavior, weighted by  
 the perceived power of the resources and obstacles to facilitate or inhibit the 
behavior (Montano et al., 1997).   See Figure 1.  
By influencing the predictor variables - attitude toward a behavior, subjective 
norm, and perceived behavioral control - the likelihood of an individual adopting or 
abstaining from a particular behavior increases.  The more favorable the attitude and 
subjective norm, and the greater the perceived control, the stronger a person’s intention to 
perform a behavior becomes (Montano et al., 1997). 
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All interventions based on the TPB should define their target behavior in terms of 
its Target, Action, Context, and Time (TACT) (Francis, Eccles, Johnston, Walker, 
Grimshaw, Foy, Kaner, Smith, & Bonetti, 2004; Ajzen, 2002).  For example, consider the 
behavior of abstaining from drug use.  The target is current persons who use drugs, the 
action is abstaining from drugs, the context is drug use or addiction, and the time is 
during and post intervention.  For safer sex practices, the target is people who do not 
engage in safer sex practices, the action is condom use, the context is risky sexual 
behaviors, and the time is during and post intervention. 
 
Figure 1. Theory of Planned Behavior 
 
Source:  Ajzen and Fishbein, 1980; cited in Montano et al., 1997, p. 87. 
To utilize the TPB, a questionnaire must be developed to assess the attitudes 
toward a behavior, the subjective norm, and the perceived control (Ajzen, 2002).  The 
first step constructing a TPB questionnaire is to conduct elicitation interviews (Ajzen, 
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2002).  Elicitation interviews are semi-structured, open-ended interviews given to 
individuals of the target population; for this study, current and past drug users with 
children were interviewed by the Taking it to Treatment Court outreach workers 
(Appendix A).  The elicitation interviewer asks questions pertaining to positive and 
negative outcomes or attributes associated with the desired behavior, individuals the 
subject values and listens to on issues concerning the behavior in question, factors that 
facilitate or obstruct the practice of the desired behavior, and feelings toward performing 
the behavior (Montano et al, 1997). The information gathered from the elicitation 
interviews is then analyzed for content on behavioral outcomes, normative referents, and 
perceived control factors.  The identified factors are used to develop TPB measures on 
behavior, subjective norm and perceived control to be used on the final TPB 
questionnaire (Montano et al., 1997). 
The TPB questionnaires are given to members of the chosen target population and 
scored.  Each item that assesses the individuals attitudes towards a behavior, subjective 
norm, or perceived control on the TPB questionnaire are determined by a seven-point 
Likert-like Scale (Montano, et al, 1997).  For example, an individual will mark where 
their attitude toward a behaviors lies on a scale from strongly agree to strongly disagree.  
Based on the individuals’ responses a score is calculated for each measure.  The score is 
used to predict whether or not the individual will engage or avoid the target behavior 
(Ajzen, 2002).  The results of the individuals’ responses are also useful to help 
researchers identify factors that should be targeted for intervention efforts.  The 
intervention efforts should target all constructs of the TPB model in order to maximize 
effectiveness.   For example, “attempting to modify control beliefs concerning factors 
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that facilitate carrying out one’s intention will not be effective if a person is not 
motivated to perform the behavior in the first place.  Conversely, changing attitude and 
intention may not result in behavioral change if the person holds strong control beliefs 
about conditions that constrain the behavior” (Montano et al. 1997, p. 109).  Finally, it is 
important to administer the TPB questionnaire before and after an intervention to 
evaluate the impact the intervention has on individuals’ attitudes toward behavior, 
subjective norm, and perceived control.  If changes are not found, adjustment can be 
made based on TPB measures (Montano et al., 1997). 
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CHAPTER III 
Methods 
 
Hepatitis C and HIV infection are serious threats to persons who use injection drugs 
everywhere.  Although HIV incidence rates are dropping among this population, HCV 
infection remains high.  More prevention efforts and educational programs are needed to 
increase person’s who use injection drugs awareness of the behaviors that increase their 
probability of contracting HIV and HCV.  It is also important for persons who use 
injection drugs to know their disease status so they can begin medical treatments if 
necessary and learn how to prevent the spread of HIV and/or HCV.  The intervention 
examined in this study, Taking it to Treatment Court, aims to educate persons recovering 
from drug use on harm reduction methods to decrease the spread of HIV and HCV.  The 
following sections examine the methods used to evaluate TITTC. 
 
Research Design 
This study utilized a mixed methods approach to program evaluation.  Researchers 
gathered information from participants enrolled in Taking it to Treatment Court in 
Yellowstone County using both quantitative and qualitative data collection and analysis 
methods.  Two methods were used to collect quantitative data; 1) a pretest/posttest non-
experimental design and (2) collection of urinalysis and arrest report data from YCFDTC.  
The survey consisted of four sections and was developed based on the Theory of Planned 
behavior.  Demographic data and information about the individual’s attitudes, beliefs, 
subjective norms, and control factors related to safer sex practices and abstinence from 
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drug use were collected.  The survey also measured knowledge about HIV and HCV.  
The survey was administered immediately before the intervention, two weeks post 
intervention and at a three month follow-up. Researchers looked for changes over time 
related to the TITTC intervention.   
Urinalysis (UA) testing and arrest report data were collected from the YCFDTC.  
Participants of the YCFDTC are remanded to frequent urinalysis testing.  These data 
were used as a comparison to the self reported data recorded for drug use on the survey.   
The qualitative component of the study utilized focus group interviews.  
Participants were asked to recall their experiences of participation in TITTC, what they 
liked and did not like about the intervention, and the impact, if any, the intervention had 
on their lives.  Researchers looked for major themes regarding participants’ perceptions 
of the effects of the intervention on their HIV/HCV risk behaviors. 
 
Description of the Target Population 
The target population for the Taking it to Treatment Court Evaluation Survey, Urinalysis 
and Arrest Report Data consisted of the individuals enrolled in Yellowstone Family Drug 
Treatment Court between August 2009 and April 2010.  Individuals involved in the focus 
groups were clients enrolled in the YCFDTC from December 2008 to December 2009.   
The YCFDTC serves substance abusing parents with child abuse and/or neglect charges 
related to drug use in Yellowstone County, Montana.    The families are involved with the 
Montana Department of Health and Human Services-Child and Family Services Division 
(Roche, 2008).  Participants of YCFDTC must be at least 18 years old.  
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Protection of Human Subjects 
All research materials were approved by the Institutional Review Board (IRB) at the 
University of Montana to ensure protection of human rights.  Information was collected 
on a voluntary basis and responses were anonymous (See Appendix F). 
 
Sample Selection 
 
Evaluation Survey, Urinalysis and Arrest Reports 
The sample for the quantitative portion of the study consisted of all individuals enrolled 
in Taking it to Treatment Court from August 2009 to April 2010.  Clients of YCFDTC 
during this time were given a research packet along with a $10 cash incentive at the start 
of TITTC requesting their participation in the study.  Willing participants were asked to 
read and sign the consent form, complete the survey, and place the completed survey in a 
sealed envelope that was collected by the intervention outreach worker.  Given the low 
number of clients enrolled in YCFDTC each year and the ethical issues associated with 
withholding information, finding a control group was determined unfeasible. 
 
Focus Group 
The sample for the qualitative portion of the study consisted of clients enrolled in TITTC 
from December 2008 to December 2009. Clients were approached by the outreach 
workers to participate in a focus group.  A written invitation was distributed to past 
clients.  The invitation contained a brief explanation of the focus group procedures and 
asked the client to check a box indicating that they were “willing” or “not willing” to 
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participate.  Individuals who agreed to participate were asked to provide e-mail or phone 
contact information and return the invitation to the outreach workers.   
 
Data Collection 
Data were collected using three different methods:  a four part survey, focus group 
interviews, and urinalysis (UA) and arrest reports.  Survey and focus group data were 
collected from intervention participants who volunteered for this study.  Urinalysis and 
arrest report records on the target population was acquired through the Drug Court 
Coordinator of the YCFDTC.  
 
Evaluation Survey Data 
All clients participating in Taking it to Treatment Court were given a packet of 
information before the intervention began.  The packet included a cover letter, an 
informed consent, and a $10.00 cash incentive to complete the survey.  The packets were 
handed out to participants by the outreach workers who conduct TITTC.  Participants 
were asked to place a unique identifier at the top of the survey for the purpose of 
matching pre, post and three month follow-up surveys. When finished, the completed 
surveys were placed in a manila envelope by the participants.  The envelope was then 
mailed to the researchers by the outreach worker.    
The post test surveys were mailed to the study participants by the outreach 
workers who routinely ask program participants’ to provide them with names and 
addresses for the purpose of offering future social support and information as needed. 
Follow-up surveys were mailed to participants two weeks post intervention and again at 
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three months post intervention.  Each follow-up packet contained a brief explanation of 
the study, a survey, a $10.00 cash incentive, and a stamped, self-addressed envelope 
addressed to the researchers at the University of Montana. 
 
Focus Group Data 
The outreach worker contacted former TITTC participants and invited them to participate 
in a focus group. The outreach workers gave the names of willing participants to the 
YCFDTC Coordinator who scheduled the time and place for the focus groups to occur.  
Each focus group was held in a private conference room in the evening and lasted 
approximately one hour.  At the beginning of each session the researchers gave an 
overview of the study and handed out consent forms.  Prior to starting the group, study 
volunteers were reminded the focus groups would be voice recorded, and no identifying 
information would be linked to the information collected.  A $30.00 cash incentive, pizza 
and beverages were offered to the participants.   Additionally, participants were reminded 
they were free to discontinue their participation at any time and keep the incentive 
money.  During the focus groups one researcher asked the group questions while the 
second researcher recorded responses on paper.   
 
Urinalysis and Arrest Report Data 
Participants who completed the survey filled out a separate form with their name, contact 
information, and unique identifier.  The unique identifier is the same identifier listed on 
the participants’ surveys.  The form was kept with the outreach workers who conducted 
TITTC.  When the UA and arrest report data were needed the outreach worker supplied 
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the unique identifier to the YCFDTC Coordinator who matched the names of the clients 
to the identifier.  The researchers then contacted the YCFDTC Coordinator who supplied 
the data via e-mail.  Only the YCFDTC Coordinator and outreach worker had access to 
the information connecting the clients’ name to the identifier.  The data collected were 
matched to the respective participant survey with the unique identifier.  This allowed the 
researchers to compare the UA and arrest report data with the self report survey data 
without compromising the identity of the YCFDTC client.   
 
Instruments 
 
Taking it to Treatment Court: Evaluation Survey 
Participants were given a survey pre and post intervention and again at a three month 
follow-up.  The survey was 14 pages and consisted of four sections:  1) Demographics, 2) 
Theory of Planned Behavior Questionnaire, 3) HIV Knowledge Questionnaire, and 4) 
HCV Knowledge Questionnaire.   The survey responses were made anonymous to protect 
the identities of clients served by YCFDTC (Appendix B). Informed consent forms and 
completed surveys were collected separately to maintain anonymity of participants.  The 
following sections provide an in-depth examination of each part of the survey. 
 
Section 1:  Demographics 
Participants were asked for basic demographic data such as age, sex, number of children, 
race, education level, employment status, and marital status.  A unique identifier question 
40 
 
was also included at the top of the survey for the purpose of matching pre and post-test 
surveys and UA and arrest report data.  
 
Section 2:  Theory of Planned Behavior 
A questionnaire was constructed to measure the variables in the Theory of Planned 
Behavior (TPB) related to intention to change behavior.  Variables measured include 
attitudes, beliefs, subjective norm, and control factors associated with safer sex practices 
and abstinence from drug use (Appendix B).    
 
Elicitation Interviews 
A critical step in the application of the TPB involves conducting open-ended elicitation 
interviews to identify the relevant behavioral outcomes, and referents for each particular 
behavior and population under investigation (Glanz, Rimer and Lewis, 2002).  Montano 
et al (1997) recommends conducting elicitation interviews with individuals who are 
currently engaging in the desired behavior and with individuals who are no longer 
engaging in the desired behavior. Participants for the elicitation interviews were recruited 
by the intervention outreach workers.  The open-ended interview questions were sent via 
mail on February 10, 2009 to sixteen individuals.  Participants were asked their current 
drug use status. The results were as follows:  
 eight individuals were recovering drug users,  
 two individuals were current users with intentions to stop using, and 
  six individuals were current drug users with no intention to stop using.      
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  The elicitation interview consisted of nine questions on drug use and nine 
questions on safer sex practices (Appendix A). The responses to these questions were 
used to develop the TPB questionnaire.  Once it was constructed, a review of the TPB 
questionnaire was undertaken by experts on HIV and HCV at the Montana Department of 
Public Health and Human Services, researchers at the University of Montana, and the 
intervention outreach workers.  Upon completion of this review, the questionnaire was 
pilot tested by former and current individuals who use drugs and have children, including 
former participants of TITTC.   
 
Pilot Test 
The Theory of Planned Behavior Survey was pilot tested in July of 2009.  The purpose of 
the pilot test was to determine internal consistency and reliability.  Fifty five pilot test 
surveys were distributed by the TITTC outreach workers to current and past drug users.  
Of these, fifty were returned for a response rate of 92.7 percent.  Data were entered into 
SPSS and Excel.   
Internal consistency was calculated on the overall scores for the TPB Drug Use 
and Safer Sex Questionnaire using Cronbach’s Alpha.  Generally a reliability of 0.70 is a 
sufficient score for a survey instrument; however, it is more desirable for each subscale to 
fall in the range of 0.80 or higher, and the entire questionnaire to have a reliability of 0.90 
or higher (Garson, 2009; uSPEQ, 2008; Gliem and Gliem, 2003).  For the entire 
questionnaire, including the Drug and Safer Sex Sections, Cronbach’s Alpha was (.916), 
indicating high internal consistency.  When ran individually, the Drug Use Section and 
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the Safer Sex Section of the TPB Survey both had high internal consistency 
independently, with α = 0.899 and α = 0.897, respectively.   
The Drug Use and Safer Sex Questionnaires are divided into three sub sections 
which correlate to the concepts of the TPB; attitude beliefs, subjective norm, and control 
beliefs.  The reliability co-efficient for each sub section of the Drug Use and Safer Sex 
Questionnaires were calculated using Spearman-Brown split half reliability co-efficient.  
The results were: 
 Drug Use:  Attitude = .615; Subjective Norm = .53; Behavioral Control = 
.737, and 
 Safer Sex:  Attitude = .801; Subjective Norm = .667; Behavioral Control = 
.854.   
Generally, a co-efficient of 0.80 or higher is considered adequate reliability (Garson, 
2009).  A co-efficient of 0.80 or higher was found for the Safer Sex attitude and 
behavioral control sections of the questionnaire.  A common cutoff for reliability is a co-
efficient of 0.60 (Garson, 2009).  The only section of the questionnaire that fell below 
this mark was Drug Use: Subjective Norm. The Drug Use subjective norm may have 
yielded a low co-efficient because this section consisted of only eight questions.  
Increasing the number of questions on a survey can drive the alpha score up to an 
adequate level (Garson, 2009).  
The final TPB portion of the survey had 87 items, with 50 questions related to 
drug use, 30 questions related to safer sex practices, and seven self report items regarding 
drug use, safer sex practices and HIV/HCV health status.  The TPB survey assessed three 
areas: 1) attitudes and beliefs toward drug use and safer sex behaviors; 2) subjective norm 
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based on factors that reinforce or dissuade drug use and safer sex behaviors; and 3) 
feelings of control over the behaviors related to drug use and safer sex.  
The TPB portion of the survey was scored based on recommendations by Francis 
et al. (2004). Based on these recommendations, a total score for the three constructs - 
attitudes towards a behavior, subjective norm and behavioral control - were obtained for 
each participant.  Each construct had an indirect measure. To calculate the score of an 
indirect measure for any of the three constructs the belief score related to that construct 
was multiplied by the corresponding motivation to comply score (Francis et al., 2004).  
The resulting products for each section were summed to create an overall score for 
attitude, subjective norm, and control belief.  The higher an individual’s scores were, the 
more likely they are to perform the behavior in question.  There are three direct measures 
questions on the survey that utilize the five point Likert-like scale as well.  Each direct 
measure question has a four part answer.  To calculate the score of a direct measure 
question the point values corresponding to the answers supplied are averaged giving a 
value between one and five.  The higher the score the more likely a participants is to 
perform the behavior in question (Francis et al, 2004).         
 
Section 3:  HIV Knowledge 
The HIV knowledge questionnaire used in this study was developed by Carey, Morrision-
Beedy, and Johnson (1997) (Appendix B).  This questionnaire has 45 true/false questions 
related to the transmission, prevention, and consequences of HIV infection.  The HIV 
Knowledge Questionnaire (HIV-K-Q) was extensively tested by the authors.  Carey et 
al.’s (1997) study included a scale construction and formative evaluation, item and factor 
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analysis, generalization of the factor solution, reliability, validity, reading level, and 
completion time required.  Measures found the HIV-K-Q was internally consistent and 
stable over three month intervals.  Validity analysis also found the HIV-K-Q to not be 
associated with other constructs like social desirability, negative or positive mood, self-
esteem, depression, dyadic adjustment, sexual satisfaction, or attitudes towards condoms 
(Carey et al., 1997).  The HIV-K-Q is written at a sixth grade level and takes 
approximately seven minutes to complete (Carey et al., 1997).  
Two additional items were included in the HIV-K-Q regarding anti-retroviral drugs.  
Given the HIV-K-Q is an older instrument it did not have items addressing persons who 
are positive for HIV and take anti-retroviral drugs.   The following true/false/don’t know 
questions were added: 
1. A person cannot get HIV by having sex with a person who is HIV+ but is taking 
anti-retroviral drugs, and 
2. A person cannot get HIV from a person who is HIV+ and has a zero viral load. 
The questionnaire was scored by summing the total number of correct answers.  
The purpose of the HIV-K-Q was to determine if there were gains in HIV knowledge 
among the participants in Taking it to Treatment Court over time.  
 
Section 4:  HCV Knowledge 
The Hepatitis C Knowledge Questionnaire (HCV-K-Q) was developed by the researchers 
(Appendix B).  This 22 item questionnaire was developed based on HCV knowledge 
gained by the researchers through a systematic review of literature about transmission, 
prevention, and consequences of HCV infection.  Content and face validity were 
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established through a review of the HCV-K-Q by a national HCV expert, HIV/STD 
prevention staff at MT DPHHS, university professors, and the Taking it to Treatment 
Court outreach workers.   
 
Pilot Test 
Once the survey was reviewed by experts it was pilot tested by 51 YCFDTC participants 
enrolled or previously enrolled in Taking it to Treatment Court in July of 2009.  A total 
of fifty five surveys were mailed out, for a return rate of 92.7 percent.  The results of the 
pilot test were not included as part of the final study, but were used to improve the 
content and face validity of the survey.  Data were entered into SPSS and Excel.  
Spearman Brown split half reliability coefficient was calculated and the instrument was 
found to have adequate reliability (0.793) (Garson, 2009).   
The questionnaire was scored by summing the total number of correct answers.  
The purpose of the HCV-K-Q was to determine if there were gains in HCV knowledge 
among the participants in TITTC over time. 
   
Taking it to Treatment Court: Focus Groups 
Questions for the focus groups were developed by the researchers to obtain an 
understanding of the participants’ perceptions of Taking it to Treatment Court and the 
outreach workers who conduct the intervention.  The Theory of Planned Behavior served 
as the foundation for the development of the focus group interview guide.  Questions 
asked pertained to the effects the intervention may or may not have had on their attitudes, 
sense of support, and confidence to abstain from drugs and practice safer sex.  When 
46 
 
necessary, more specific questions were asked regarding how the intervention influenced 
knowledge about prevention, transmission, and consequences of HIV and HCV infection 
and if the knowledge gained increased the likelihood to engage in preventative behaviors 
(See Appendix D).  
 
Taking it to Treatment Court: Urinalysis and Arrest Reports 
Urinalysis and arrest report data were collected for the purpose of comparing 
participants’ self-reported behavior on the TITTC evaluation survey with more objective 
information. Yellowstone County Family Drug Treatment Court requires all participants 
to be drug and alcohol tested on a weekly basis by urinalysis (UA).  Drug testing is 
randomized among clients, so individuals are unaware of when or how many times a 
month they will be called for screening (Roche, 2008).  Results of all UAs are given to 
the YCFDTC Coordinator daily and included in the participant’s Client Status Report that 
is used during clients’ treatment meeting and hearings (Roche, 2008).  YCFDTC 
maintains participant’s arrest reports while in treatment as well.  These records were 
compared to the TPB intentions to abstain from drug use scores to look for a correlation 
between intentions to abstain from drugs and actually abstaining. 
   
Data Analysis 
 
Taking it to Treatment Court: Evaluation Survey 
Data from the questionnaires were entered into the SPSS statistical package and 
descriptive statistics were calculated.  The degree to which intentions to change risk 
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behaviors were affected by the intervention was examined and described for each of the 
three constructs of the behavior change model.  HIV and HCV knowledge scores were 
calculated as well.  Mean scores, ranges, and standard deviations for pre, post and three 
month follow-up survey results were presented in charts.  Repeated measures ANOVA 
was used to determine statistically significant differences in TPB construct scores and 
HIV and HCV knowledge scores over time.  Due to the small n in the study combined 
with the low return rate on the three month follow-up survey, the researchers also ran t-
tests on the pretest and two week posttest data to determine if there were any short term 
statistically significant gains.  
 In addition, the relationship between the intent to perform behaviors (the predictor 
variable reported on the post-test survey) and the actual behaviors (the criterion variable 
representing mandatory drug tests) was examined.  Bivariate correlation statistics was 
used to calculate an r² value.  Researchers’ predict a positive relationship exists between 
intent to perform a behavior and actually performing the behavior once participants 
complete TITTC.  
 
Taking it to Treatment Court:  Focus Group 
Analysis of the focus group data was based on qualitative research techniques (Creswell, 
1998).  The focus groups were taped and notes were taken. Immediately following the 
focus group, the researchers’ recorded on a contact summary sheet general impressions of 
the interview process including length of interview, location, a general physical 
description of the interviewees, and any notable or unusual circumstances.  The tapes 
were transcribed completely and compared to the notes to check for accuracy.  The first 
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part of the analysis involved reading the transcriptions through numerous times and 
taking notes in the margins.   The emergent themes and concepts were organized into 
separate categories.  Lastly, the emergent themes were compared and condensed into 
overall themes and sub-themes.  
 
Taking it to Treatment Court: Urinalysis and Arrest Reports 
Urinalysis (UA) and arrest report data were obtained from the YCFDTC Coordinator 
three months post intervention.  Data were collected from three months pre intervention 
to three months post intervention, corresponding to the self report questions on drug use 
and arrest history from the evaluation survey.  Results of the UA were recorded on a 
dichotomous scale as passing the drug screen, indicating no presence of drugs, or failing, 
indicating drug use.  These results were compared to the self-reported drug use behavior. 
Arrest report data was examined in terms of recidivism.  The use of UA and arrest report 
data ultimately contributed to the validation of responses from the evaluation survey and 
determined if a correlation existed between intention to abstain from drugs and actual 
behavior.  
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CHAPTER IV 
Results 
 
The purpose of this study was to evaluate Taking it to Treatment Court, an HIV and HCV 
prevention intervention for clients of the Yellowstone County Family Drug Treatment 
Court.  This study examined the effects of the intervention on participants’ knowledge of 
HIV and HCV and on their behavioral intentions to practice safer sex and abstain from 
drugs.  The following section reports the findings of this study.   
 
Taking it to Treatment Court:  Evaluation Survey 
 
Section 1:  Demographics 
Eleven participants entered the study; however one dropped out of the YCFDTC system 
during the evaluation period of this study and did not complete the post test evaluations.  
Data from this participant was excluded in this analysis.  Of the ten participants in the 
study there were: 
 8 females and  
 2 males.   
The average age of participants was 28.2, with a range from 20 to 37 years old.  Race was 
indicated as follows:   
 6 white (non-hispanic),  
 2 American Indian/Alaskan Native,  
 1 Hispanic/Latino/Chicano, and  
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 1 not indicated.   
Nine participants were heterosexual and one was bi-sexual.   Seven participants indicated 
they were single parents, one was separated, and one lived with a partner.  The total 
number of children participants reported was as follows:  
 1 child (n=3), 
 2 children (n=3), 
 3 children (n=1), and  
 4 children (n=3).   
Four participants did not have a high school diploma, four received a high school 
diploma or GED, and two indicated they had attended some college.  Six participants 
indicated they were employed; however none had an income level over $10,000 per year.  
The majority (n=7) had income levels below $6,000 and two ranged from $6,000 to 
$10,000.  One participant did not indicate an income level.           
 
Section 2:  Theory of Planned Behavior 
All ten participants completed the Taking it to Treatment Court pre-evaluation survey and 
two weeks post intervention evaluation survey for a 100% return rate.  The three month 
follow-up survey was completed by five participants.  The remaining five participants 
were sent the three month follow-up survey, but failed to return it for a response rate of 
50%.  The low return rate of the three month follow up survey resulted in the researchers 
calculating a paired sample t test with the pretest and two week posttest survey.   A 
repeated measures ANOVA was run on the five participants with all three data points.  A 
p value of .05 was set to determine significance.   
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Score ranges on the Theory of Planned Behavior survey are based on a five point 
Likert-like scale and total number of questions.  The lower the score the lower an 
individual’s intention is to perform a behavior, the higher the score the higher an 
individual’s intention is to perform a behavior.  For each section of the TPB survey 
scores were calculated to determine the possible range of total scores. The ranges are 
listed in the tables below.   
  
Drug Use Survey 
The TPB Drug Use Survey was designed to measure participants’ intentions to abstain 
from drug use.  Mean scores, ranges, and standard deviations for the drug use section of 
the questionnaire were calculated.  Pre, post and three month follow-up scores for the 
total questionnaire and three subscales of the TPB are illustrated in tables’ one through 
six below.  Results of the paired samples t test and repeated measures ANOVA follow the 
respective table.   
 
Table 1.  TPB Drug Use Survey – Total Scores 
TPB INTENTION TO ABSTAIN FROM DRUGS  
 Mean Score  
 
Range 
(24-600 possible) 
Standard 
Deviation 
Pre Test 
353.0 (n=10) 267-433 51.8 
Post Test 
401.5 (n=10) 281-508 68.2 
3 Month 
Follow Up 
387.8 (n=5) 286-435 58.4 
 
The TPB Drug Use Survey was designed to measure participants’ overall 
intentions to abstain from drug use, including attitudinal, normative and control beliefs.  
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A paired samples t test was calculated for the TPB Drug Use Survey total scores from 
pretest to two week posttest.  The t value = -2.313 and p= .046, which is significant at the 
p=.05 level.  A repeated measures ANOVA was run on the TPB Drug Use Total scores 
for pre, post, and three month posttests for the five participants with complete data sets.  
No significance was found (p=.433).   
A score below 216 on this subscale indicates a weak intention to abstain from 
drug use, while a score above 216 indicates a strong intention to abstain from drug use.  
The three calculated means for this construct show that overall participants had strong 
intentions to abstain from drug use.  The range column shows that none of the individual 
participants scored below a 216 on the pretest indicating each participant had a relatively 
strong intention to abstain from drugs prior to engaging in TITTC.  The intentions 
towards abstaining from drugs scores fell during the three month follow-up but remained 
higher than the baseline scores.    
 
Table 2.  TPB Drug Use Attitude Sub-Scale Scores 
TPB DRUG USE ATTITUDE SCORES 
 Mean Score  
 
Range 
(10-250 possible) 
Standard 
Deviation 
Pre Test 
151.8 (n=10) 98-195 32.3 
Post Test 
184.3 (n=10) 129-234 33.2 
3 Month 
 Follow Up 
162.8 (n=5) 94-196 40.7 
 
The TPB Drug Use Attitude sub-scale was designed to measure attitudinal beliefs 
towards abstaining from drug use.  Attitudes toward abstaining from drug use are based 
on behavioral beliefs toward the action and an evaluation of the behavioral outcomes 
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associated with action (Montano et al., 1997).  A paired samples t test was calculated for 
the TPB Drug Use Attitudes scores from pretest to two week posttest.  The t value =         
-2.43 and p= .038, which is significant at the p=.05 level. A repeated measures ANOVA 
was run on the TPB Drug Use Attitudes scores for pre, post, and three month post tests 
for the five participants with complete data sets.  No significance was found (p=.379). 
 A score below 90 on this subscale indicates a negative attitude toward abstaining 
from drug use, while a score above 90 indicates a positive attitude toward abstaining 
from drug use.  The three calculated means for this construct show overall participants 
had positive attitudes towards abstaining from drug use.  The range column shows that 
none of the individual participants scored below a 90 on the pretest indicating each 
participant had a relatively positive attitude toward abstaining from drug use prior to 
engaging in TITTC.  The positive attitudes were maintained through the three month 
follow up.   
 
Table 3.  TPB Drug Use Subjective Norm Sub-Scale Scores 
TPB DRUG USE SUBJECTIVE NORM SCORES 
 Mean Score  
 
Range 
(4-100 possible) 
Standard 
Deviation 
Pre Test 
77.7 (n=10) 40-95 16.1 
Post Test 
82.0 (n=10) 50-100 16.3 
3 Month 
 Follow Up 
86 (n=5) 80-95 6.5 
 
The TPB Drug Use Subjective Norm sub-scale was designed to measure 
normative beliefs towards abstaining from drug use.  Normative beliefs are based on 
whether or not significant others approve of the behavior, and the motivation to comply 
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with significant others beliefs regarding performing or abstaining from the behavior 
(Montano et al., 1997).   
A paired samples t test was calculated for the TPB Drug Use Subjective Norm 
scores from pretest to two week posttest.  The t value = -.908 and p= .388, which is not 
significant at the p=.05 level.  A repeated measures ANOVA was run on the TPB Drug 
Use Subjective Norm scores for pre, post, and three month post tests for the five 
participants with complete data sets.  No significance was found (p=.827).    
A score below 36 on this subscale indicates a negative normative belief, while a 
score above 36 indicates a positive normative belief.  The three calculated means for this 
construct show overall participants had positive normative beliefs towards abstaining 
from drug use.  The range column shows that none of the individual participants scored 
below a 36 on the pretest indicating each participant had relatively positive normative 
beliefs toward abstaining from drugs prior to engaging in TITTC.  The positive normative 
beliefs were maintained through the three month follow up.   
 
Table 4.  TPB Drug Use Control Sub-Scale Scores 
TPB DRUG USE CONTROL SCORES 
 Mean Score  
 
Range 
(10-250 possible) 
Standard 
Deviation 
Pre Test 
123.5 (n=10) 89-149 22.9 
Post Test 
135.2 (n=10) 90-179 31.5 
3 Month 
Follow Up 
139 (n=5) 112-191 30.7 
 
The TPB Drug Use Control sub-scale was designed to measure participants’ 
perceived control beliefs towards abstaining from drug use.  Perceived control beliefs are 
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based on resource availability for and obstacles to performing the behavior, weighted by 
the perceived power of the resources and obstacles to facilitate or inhibit the behavior 
(Montano et al., 1997).  A paired samples t test was calculated for the TPB Drug Use 
Control scores from pretest to two week posttest.  The t value = -1.376 and p= .202, 
which is not significant at the p=.05 level. A repeated measures ANOVA was run on the 
TPB Drug Use Control scores for pre, post, and three month follow up post tests for the 
five participants with complete data sets.  No significance was found (p=.458).  
 A score below 90 on this subscale indicates low perceived control beliefs towards 
abstaining from drug use, while a score above 90 indicates high perceived control beliefs 
towards abstaining from drug use.  The three calculated means for this construct show 
overall participants had positive perceived control beliefs towards abstaining from drug 
use.  The range column shows that a participant scored just below 90 on the pretest, 
however overall participants had relatively high perceived control beliefs prior to 
engaging in TITTC.  The positive control beliefs were maintained through the three 
month follow up.   
Two direct measures questions were asked related to drug use in the attitude and 
control section.  For a direct measure, the participant is given a statement followed by 
four sub scales consisting of dichotomous terms ranked from 1 through 5 on a Likert-like 
scale.  For example, the phrase “Overall drug use is …” is followed by four pairs of terms 
such as “enjoyable” and “not enjoyable”. The answers provided by participants are 
averaged with one indicating negative attitudes or feelings of control towards the 
behavior and five indicating positive attitudes or feelings of control towards the behavior.  
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The following are tables with the means, ranges and standard deviations of these 
constructs. 
 
Table 5.  TPB Direct Measure Drug Use Attitude Scores 
TPB DIRECT DRUG USE ATTITUDE SCORES 
 Mean Score  
 
Range 
(1-5 possible) 
Standard 
Deviation 
Pre Test 
3.4 (n=10) 1.75-5 1.2 
Post Test 
3.5 (n=10) 2.5-5 0.72 
3 Month 
Follow Up 
3.86 (n=5) 3.3-4 .31 
  
A paired samples t test was calculated for the TPB Direct Drug Use Attitudes 
scores from pretest to two week pos test.  The t value = -.214 and p= .835, which is not 
significant at the p=.05 level.  A repeated measures ANOVA was run on the TPB Direct 
Drug Use Attitudes scores for pre, post, and three month post tests for the five 
participants with complete data sets.  No significance was found (p=.569). 
A score below three on this subscale indicates negative direct attitudinal beliefs, 
while a score above three indicates positive direct attitudinal beliefs. The range column 
shows some participants scored below and above a three on the pretest and two week 
posttest, indicating direct attitudinal beliefs prior to engaging in TITTC were mixed.  By 
the three month follow up all participants (n=5) had scores over three. 
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Table 6.  Direct Measure Drug Use Control Scores 
TPB DIRECT DRUG USE CONTROL SCORES 
 Mean Score  
 
Range 
(1-5 possible) 
Standard 
Deviation 
Pre Test 
3.9 (n=10) 1-5 1.6 
Post Test 
4.8 (n=10) 3.75-5 0.41 
3 Month 
Follow Up 
4.85 (n=5) 4.25-5 .34 
 
A paired samples t test was calculated for the TPB Direct Drug Use Control 
scores from pretest to two week posttest.  The t value = -1.75 and p= .114, which is not 
significant at the p=.05 level.  A repeated measures ANOVA was run on the TPB Direct 
Drug Use Control scores for pre, post, and three month post tests for the five participants 
with complete data sets.  No significance was found (p=.738). 
A score below three on this subscale indicates low direct control beliefs, while a 
score above three indicates high direct control beliefs.  The range column shows some 
participants scored below and some scored above a three on the pretest, indicating direct 
control beliefs prior to engaging in TITTC were mixed.  By the two week posttest all 
participants had scores over three which were maintained over time. 
 
Safer Sex Survey 
The TPB Safer Sex Survey was designed to measure participants’ intentions to practice 
safer sex, as defined by using condoms.  Mean scores, ranges, and standard deviations for 
the safer sex section of the questionnaires were calculated.  Pre, post and three month 
follow-up scores for the total questionnaire and the three subscales of the TPB are 
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illustrated in tables seven through eleven below.  Results of the paired samples t test 
follow the respective table. 
 
Table 7.  TPB Safer Sex Survey - Total Scores 
TPB SAFER SEX TOTAL SCORES 
 Mean Score  
 
Range 
(15-375 possible) 
Standard 
Deviation 
Pre Test 
189.2 (n=10) 117-243 47.8 
Post Test 
198.2 (n=10) 99-317 71.5 
3 Month 
Follow Up 
212.2 (n=5) 125-276 63.1 
 
A paired samples t test was calculated for the TPB Safer Sex Total scores from 
pretest to two week posttest.  The t value = -.592 and p= .568, which is not significant at 
the p=.05 level.  A repeated measures ANOVA was run on the TPB Safer Sex Total 
scores for pre, post, and three month post tests for the five participants with complete 
data sets.  No significance was found (p=.914). 
A score below 135 on this construct indicates weak intentions to practice safer 
sex, while a score above 135 indicates strong intentions to practice safer sex.    The range 
column, shows that some individual participant’s intentions to practice safer sex were 
weak prior to entering TITTC.  The weak individual intentions towards practicing safer 
sex were unchanged through the three month follow up.  Findings also show some 
individual’s intentions were strong from pretest and were maintained through the three 
month follow up test.    
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Table 8.  TPB Safer Sex Attitude Sub-Scale Scores 
TPB SAFER SEX ATTITUDE SCORES 
 Mean Score  
 
Range 
(8-200 possible) 
Standard 
Deviation 
Pre Test 
104.8 (n=10) 65-155 23.6 
Post Test 
97.5 (n=10) 58-157 32.1 
3 Month  
Follow Up 
 109 (n=5) 68-137 32.0 
 
The TPB Safer Sex Attitude sub-scale was designed to measure attitudinal beliefs 
towards practicing safer sex.  A paired samples t test was calculated for the TPB Safer 
Sex Attitude scores from pre test to two week post test.  The t value = .816 and p= .435, 
which is not significant at the p=.05 level.  A repeated measures ANOVA was run on the 
TPB Safer Sex Attitudes scores for pre, post, and three month post tests for the five 
participants with complete data sets.   No significance was found (p=.743). 
A score below 72 on this subscale indicates a negative attitude toward practicing 
safer sex, while a score above 72 indicates a positive attitude toward practicing safer sex.  
The range column shows that some individual participant’s attitudes towards practicing 
safer sex were negative prior to entering TITTC and stayed negative over time.  Findings 
also show some individual’s attitudes were positive from pretest and were maintained 
through the three month follow up test.    
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Table 9.  Safer Sex Subjective Norm Sub-Scale Scores 
TPB SAFER SEX SUBJECTIVE NORM SCORES 
 Mean Score  
 
Range 
(3-75 possible) 
Standard 
Deviation 
Pre Test 
33.9 (n=10) 3-65 21.1 
Post Test 
37.4 (n=10) 7-75 27.2 
3 Month  
Follow Up 
 45.2 (n=5) 25-70 21.3 
 
The TPB Safer Sex Subjective Norm sub scale was designed to measure 
participants’ normative beliefs towards practicing safer sex. A paired samples t test was 
calculated for the TPB Safer Sex Subjective Norm scores from pretest to two week 
posttest.  The t value = -.655 and p= .529, which is not significant at the p=.05 level.  A 
repeated measures ANOVA was run on the TPB Safer Sex Subjective Norm scores for 
pre, post, and three month post tests for the five participants with complete data sets.  No 
significance was found (p=.718). 
A score below 27 on this subscale indicates negative normative beliefs towards 
practicing safer sex, while a score above 27 indicates positive normative beliefs toward 
practicing safer sex.  The range column shows that individual participant’s normative 
beliefs towards practicing safer sex range from very negative to very positive prior to 
entering TITTC and remain this way over time.  
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Table 10.  TPB Safer Sex Control Sub-Scale Scores 
TPB SAFER SEX CONTROL SCORES 
 Mean Score  
 
Range 
(4-100 possible) 
Standard 
Deviation 
Pre Test 
 50.5 (n=10) 31-80 17.9 
Post Test 
 63.3 (n=10) 30-95 24.2 
3 Month 
Follow Up 
58 (n=5) 32-74 17.4 
 
The TPB Safer Sex Control sub scale was designed to measure participant’s 
perceived control over practicing safer sex.  A paired samples t test was calculated for the 
TPB Safer Sex Control scores from pre test to two week post test.  The t value = -1.636 
and p= .136, which is not significant at the p=.05 level.  A repeated measures ANOVA 
was run on the TPB Safer Sex Control scores for pre, post, and three month post tests for 
the five participants with complete data sets.  No significance was found (p=.325).  
 A score below 36 on this subscale indicates low perceived control beliefs towards 
practicing safer sex, while a score above 36 indicates high perceived control beliefs 
toward practicing safer sex.  The range column shows that some individual participant’s 
perceived control beliefs were slightly negative prior to entering TITTC and stayed 
slightly negative over time.  Findings also show some individual’s perceived control 
beliefs were high from pretest and these beliefs were maintained through the three month 
follow up test.    
One direct measure question was asked related to safer sex attitudes.  The 
following is a table with the means, ranges and standard deviations of this construct. 
 
 
62 
 
Table 11.  TPB Direct Measure Safer Sex Attitude Scores  
TPB DIRECT SAFER SEX ATTITUDE SCORES 
 Mean Score  
 
Range 
(1-5 possible) 
Standard 
Deviation 
Pre Test 
3.6 (n=10) 2.3-5 .85 
Post Test 
3.8 (n=10) 2.5-5 .82 
3 Month 
Follow Up 
 4.3 (n=5) 3-5 .84 
 
A paired samples t test was calculated for the TPB Direct Safer Sex Attitude 
scores from pre test to two week post test.  The t value = -1.956 and p= .082, which is 
approaching significance at the p=.05 level.   A repeated measures ANOVA was run on 
the TPB Direct Safer Sex Attitudes scores for pre, post, and three month post tests for the 
five participants with complete data sets.  No significance was found (p=.410).  
A score below three on this subscale indicates negative direct attitudinal beliefs 
towards practicing safer sex, while a score above three indicates high direct attitudinal 
beliefs towards practicing safer sex.  The range column shows some participants scored 
below and above a three on the pretest and two week posttest, indicating direct attitudinal 
beliefs prior to engaging in TITTC were mixed.  By the three month follow up all 
participants (n=5) had scores of three or above.  
 
Self Reported Data 
At the end of the TPB Survey, participants were asked 11 questions related to number of 
times the participant has been in treatment or arrested; drug use history, including 
frequency and drugs used; arrest charges; if the participant had been tested for HIV or 
63 
 
HCV and the results; and risk factors for HIV and HCV (See Appendix B).    The results 
of HIV and HCV testing and risk factors are reported below (See Table 12).  Results of 
the participants’ responses in regards to treatment, drug use history, and arrest report data 
are examined further in the Urinalysis and Arrest Report Section. 
The pretest TPB self reported data indicated that nine out of the ten participants 
had been tested for HIV, and none of those individuals tested were positive.  Half of the 
participants (n=5) had been tested for HCV, and three had positive test results (See Table 
12).  Participants were asked to indicate any risk factors they had for HIV and HCV.  The 
results were as follows: 
 injection drug use (n=5),  
 having unprotected anal sex with men (n=3),  
 having unprotected heterosexual sex (n=6), and  
 not a member of a risk group (n=2). 
The sum total of these results exceeds ten as participants were able to indicate more than 
one risk factor. 
The two week posttest TPB Self Reported data indicated again that nine out of the 
ten participants had been tested for HIV, however only eight negative test result 
responses were given.  One participant’s test result datum was missing.  At the two week 
follow up, nine participants indicated they had been tested for HCV, and four had 
positive test results (See Table 12).  Participants were asked again to indicate any risk 
factors they had for HIV and HCV.  The only result that changed from pre to two week 
post was the category Not a member of a risk group (n=4).   The one participant who had 
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not been tested for HIV was the same participant not tested for HCV.  By the three month 
follow up, this individual indicated she had still not been tested.   
 
Table 12.  HIV and HCV Testing and Test Results 
HIV/HCV TESTING AND RESULTS 
 
Participants Tested 
Participants Tested 
Positive 
HIV Pre Test 
9 (n=10) 0 
HIV Post Test 
9 (n=10) 0 
HCV Pre Test 
5 (n=10) 3 
HCV Post Test 
9 (n=10) 4 
   
 
Section 3: HIV Knowledge Questionnaire 
Ten participants completed the pre and posttest HIV Knowledge Questionnaire for a 
return rate of 100 percent.  Five participants completed the three month follow up HIV 
KQ, for a return rate of 50 percent.  Means, ranges and standard deviations for the pre, 
post and follow-up scores are reported in table 13 below.  The low return rate of the three 
month follow up survey resulted in the researchers calculating a paired sample t test with 
the pretest and two week posttest survey.  A repeated measures ANOVA was run on the 
five participants with all three data points.  A p value of .05 was set to determine 
significance.  Results of the paired samples t test and repeated measures ANOVA follow 
table 13. 
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Table 13.  HIV Knowledge Questionnaire Scores 
HIV KQ DESCRIPTIVE STATISTICS 
 Mean Score  
 
Range 
(47 Total Points) 
Standard 
Deviation 
Pre Test 
37.1 (n=10) 15-43 8.0 
Post Test 
39.8 (n=10) 31-44 3.8 
3 Month 
Follow Up 
37 (n=5) 27-43 6.37 
 
A paired samples t test was calculated for the HIV KQ from pretest to two week 
posttest.  The t value= -.923 and p=.38, which is not significant at the p=.05 level.   A 
repeated measures ANOVA was calculated for the HIV KQ for pre, post, and three 
month post tests for the five participants with complete data sets.  No significance was 
found (p=.427).    
 
Section 4: HCV Knowledge Questionnaire 
Ten participants completed the pre and posttest HCV Knowledge Questionnaire for a 
return rate of 100 percent.  Five participants completed the three month follow up HCV 
KQ, for a return rate of 50 percent.  Means, ranges and standard deviations for the pre, 
post and follow-up scores are reported in table 14 below.  The low return rate of the three 
month follow up survey resulted in the researchers calculating a paired sample t test with 
the pretest and two week posttest survey.  A repeated measures ANOVA was run on the 
five participants with all three data points.  A p value of .05 was set to determine 
significance.  Results of the paired samples t test and repeated measures ANOVA follow 
table 14. 
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Table 14.  HCV Knowledge Questionnaire Scores 
HCV KQ DESCRIPTIVE STATISTICS 
 Mean Score  
(22 Total Points) 
Range Standard 
Deviation 
Pre Test 
10.6 (n=10) 5-17 4.5 
Post Test 
16.2 (n=10) 12-20 2.5 
3 Month 
Follow Up 
16 (n=5) 11-19 3.32 
 
A paired samples t test was calculated for the HCV KQ from pre test to two week 
post test.  The t value= -5.154 and p=.001, which is significant at the p=.05 level.  A 
repeated measures ANOVA was calculated for the HCV KQ for pre, post, and three 
month post tests for the five participants with complete data sets.  There was a significant 
difference (p=.003).  The significance was between the pre and three month follow up 
survey (p=.028), and the pre and two week post survey was approaching significance 
(p=.064).  It is important to note the pre and posttest mean scores represent all ten 
participants.  The mean differences between pre, post and three month follow up tests are 
different for the five participants with complete data sets.   
 
Taking it to Treatment Court:  Focus Groups 
 
Description of Focus Groups 
Two focus groups were held on Wednesday December 16, 2009 in Billings, Montana.  
The meetings were held in a private conference room in the Family Child Services 
Building each lasting approximately one hour.  The YCFDTC Coordinator was present at 
the start of both groups to introduce clients to the researchers.  The groups were seated 
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around a conference table, dress was casual, and the participants were all friendly and 
familiar with one another.   
The first focus group was held at 4:00 PM and had six participants; one male and 
five females.  No demographic information was collected from the group, however based 
on the researcher’s observations the group consisted of three non-Hispanic whites and 
three Native Americans aged 25 to 45.  The second group immediately followed the first 
group at 5:15 PM.  The members of this group were four females, and based on 
observation were three non-Hispanic whites and one Native American aged 21 to 45.  
Participants were asked how long ago they completed Taking it to Treatment Court.  One 
participant had taken it as recent as three months prior, while the rest of the group had 
completed the course nine months to one year ago. 
 
Researcher‟s Impressions of Focus Group Process 
The purpose of the focus groups was to obtain general impressions of TITTC from 
former clients.  On a whole the participants of these focus groups were compliant, 
talkative, and friendly.  All participants contributed to the discussion, although there 
tended to be dominant voices in the dialogue.  Each group had slightly different dynamics 
that will be discussed further in the following paragraphs.  In general, the participants 
seemed unenthusiastic about participating in the focus group, but eager to assist the 
outreach workers in bettering the program and obtaining funding.  They appeared slightly 
confused as to why researchers were asking questions about a program they took nearly a 
year ago and eager to conclude the meeting.  Receiving the incentive money and getting 
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free food and beverage seemed to be the motivating factors to participate in the focus 
group.    
 
Focus Group #1 
In the first group, a participant’s daughter was present.  She was approximately 10 years 
old, and during the focus group she sat and drew pictures.  At one point in time she got 
up and left the room and came back minutes later which was distracting.  Often time’s 
participants would make light of a discussion by using jokes.  The male in the group was 
used as a scapegoat for many participants to divert attention away from the questions 
posed by the researchers.  The male and one of the females in the group were in a 
relationship which may have affected the way either of these individuals participated in 
the discussion.  One participant in this group was very quiet and only answered questions 
when directly asked.  A few times members of this group would ask if the meeting was 
nearly over, which would make other members of the group anxious to leave. 
 
Focus Group #2 
The second group had three very talkative women and one relatively quiet woman.  All 
four women knew each other well and had a lot to say that did not pertain to the questions 
asked.  As in the first group, jokes were used frequently as a way to lighten the mood.  
One of the participants was much younger than the rest and she was used as a scapegoat 
to divert attention away from the questions posed.   This same young woman would 
provide elaborate stories that were not necessarily related to TITTC or the outreach 
workers who conduct the intervention.  Her stories were distracting for the rest of the 
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group and the researchers had to continually bring the conversation back to the 
intervention. 
Overall, the depth of information provided by these two groups was very minimal.  
Neither group directly answered the questions related to the sense of support the 
intervention gave them.  The majority of answers pointed to the intervention being 
primarily a source of information about HIV and HCV.                       
 
Emergent Themes 
Data were analyzed for common themes, patterns, and constructs during the focus 
groups.  Themes that emerged during the focus groups overlapped between the two 
groups since the same questions were posed.  The following is a look at the major themes 
discussed by the participants during the focus groups. 
 
Taking it to Treatment Court was a Positive Experience 
In general, the participants believed the intervention was a positive experience.   Taking it 
to Treatment Court was described as informative, positive, relaxed, comfortable, 
thorough, personal, a chance to meet other YCFDTC participants, and delivered by 
genuine, caring outreach workers with whom they could identify.   
“I thought that it [Taking it to Treatment Court] was very positive, very um, it 
taught you a lot.  It taught me a lot about what I didn‟t know about the things that 
were taught.”  
 
“Um, when I was in the group that all of us were in…were in the Drug Court 
Program, and so I got to know people that were in that [program] better than I 
would have had that group not been in place.” 
 
“Very relaxed and comfortable.  It wasn‟t you know, awkward talking about that 
stuff you know.” 
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“They [outreach workers] kept it interesting, they didn‟t…They didn‟t make you 
feel uncomfortable.  You were welcome no matter what, they were funny, and they 
also got the point across.  [Be]cause I didn‟t know nothing about that stuff.” 
 
“They [outreach workers] were really involved with it [Taking it to Treatment 
Court] because he [an outreach worker] had it [HCV] and it, you know, that just 
made it more, ah, more sincere and more honest from them really.” 
 
“Yeah, it was realistic.  It‟s not just something, it‟s not going to happen to me, 
and here I mean, it [HCV] happened to him [outreach worker], and it could 
easily happen to me.  And it just made it more realistic.” 
 
“Once you get through the program, you say, „Wow! That was good!‟” 
 
Taking it to Treatment Court Encouraged Participants to Get Tested 
There were many times throughout the focus groups that participants brought up the 
importance of getting tested for HIV and HCV and how Taking it to Treatment Court 
encouraged them to get tested.  Participants also felt it would be a good idea to offer 
onsite HIV and HCV testing as part of TITTC in the future.   
“Yeah, for me it was like, once you learned the different ways that is it possible to 
contract, like Hep C, like if you have it, using his razor blade, you know, to shave 
my legs or something, or sharing tooth brushes, I mean you want to get tested.” 
  
“I just got tested for all of that [HIV and HCV].” 
 
“For Hep C, um, they gave me a couple of mail in test kits.” 
 
“I think that if they have taken out the option to get tested there on the spot, if that 
was taken from the class, I think it should be put back in.” 
 
 “Yeah, [be]cause a lot of times you think, um, well I never shot up or anything 
like that, so…But then they‟re [the outreach workers] like [say]you know, even 
using tooters can do it [lead to HIV/HCV infection]…” 
 
“Oh yeah.  Yeah, I mean, even though I wasn‟t an IV user, but you know, I had 
unsafe protection sex before, and you know, she [the outreach worker] let me 
know.  Especially with someone you really know.” 
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Outreach Workers Encourage Safer Sex 
It was very clear during both focus groups that the outreach workers reinforced the 
importance of practicing safer sex.  Safer sex was defined during the focus groups as 
using condoms.  Participants’ mentioned several times that their level of support for 
practicing safer sex was increased by the outreach workers.  This was achieved by the 
outreach worker’s dedication to distribute free condoms and lube to YCFDTC clients, 
education about condom negotiation, and supplying knowledge about resources for 
reproductive health issues.  
“Oh yeah, she always has them [condoms], every day she shows up there is bags 
of them.” 
 
“I mean she offers them out, she does mention this is a great way to not pass this 
[HIV] on…She [the outreach worker] does it, she gives them [condoms] to you, 
and I don‟t know… The first time I came home I had like two drawers of them.  
They are everywhere, so I mean what more of a sense of support for using 
condoms can you have then everywhere you look there is one.” 
 
“But also, you know, they you know, they tell you where you can get like free 
testing and where you can go and get like free condoms, and you know birth 
[control]…”    
 
“They [the outreach workers] just reinforced it [safer sex] a lot.” 
 
“I think I remember her [outreach worker] saying something about it 
[monogamous relationships].  [Be]cause I was like, I remember saying something 
about being married and she said that there is always a possibility [for 
contracting a disease] that he goes out or you know something.” 
 
“Yeah, I‟m not scared to tell a dude to put a condom on anymore.” 
“Maybe more comfortable than you had ever thought of it [condoms] before.  It 
was kind of like a, oh my god I couldn‟t bring that [condoms] up.  I‟d be so 
embarrassed.  But now, I mean, now you know how to bring that up.  It‟s not 
hard.” 
 
“To be able to talk to a partner about it [using condoms] maybe.” 
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“You know, and it‟s more likely for women to carry condoms in their purses now 
than it is for a man to carry a condom around with him.  Or when he knows he‟s 
going to have you know, sex, he‟ll be prepared and have them in his car or 
whatever, they just don‟t do it.  So that‟s their excuse to not use them, well I don‟t 
have it.  And if you have them, there is no reason to not use it.”   
 
“Yeah, they gave out free condoms and lube and it was awesome!” 
 
Participants gained knowledge about HIV and HCV 
Participants believed the most valuable aspect of the intervention was an increase in their 
knowledge about HIV and HCV.  Gains in knowledge about HIV and HCV were the 
primary themes discussed during both focus groups.  Participants felt the intervention did 
a good job of presenting HIV and HCV information by clearing up questions or myths 
pertaining to the viruses and did not leave them with any questions.  Overall, participants 
felt they learned more about HCV than HIV.  The HIV knowledge was described as an 
upgrade of knowledge, whereas the HCV knowledge was all fairly new material.  
Participants mentioned specific knowledge gains in the following areas:  statistics about 
HIV and HCV prevalence; where and how to get tested; effects of HIV and HCV on body 
organs;  effects of injection drug use as well as non-injection drug use on the risk of 
disease transmission; methods for protecting oneself from disease transmission; HIV and 
HCV etiology and transmission; importance of bleaching drug injecting equipment; 
negotiating condom use; resource availability for reproductive health; and effects of drug 
use on important others.     
“I liked how they showed you hands on what it did to your body, what it does to 
your body, your liver, and just talk about the liver, it was nice to see the damage.” 
 
“Just learning the statistics on HIV and Hep C in Montana and how long Hep C 
is alive.” 
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“I didn‟t know anything about Hep C until I took the class, so it was good 
information for me.”  
 
“For me it was like kind of a different scope because I have been recently 
diagnosed with Hep C.  I have had it for awhile and didn‟t know.  So that class 
really, it had a big impact because it taught me you know, what was really 
involved, you know.  Because I have a lot of misperceptions about how easily my 
kids could get it, or you know. And it really put my mind at ease and educated me 
on, on how to keep everybody safe and at the same time, you know, I was going 
through the HCV treatments.  They had a lot of information that really set my 
mind at ease, so.” 
 
“Yeah, just it was kind of like the, how long it [HCV] survives airborne, it‟s, I 
didn‟t, I wouldn‟t imagine it being able to live that long.” 
 
“I think mine was learning about the statistics back home in ____ County, you 
know because I grew up on that reservation and I know all those people pretty 
much, and to know that like so many of them you know, [have HIV and HCV], and 
they don‟t even know it.” 
 
“I felt, I felt pretty secure when I left it, you know.  I had enough knowledge to 
keep everybody I knew safe.  I mean, I wasn‟t asking questions, I really felt like 
they covered most of the area that I would have had any questions about.”  
 
“[I learned] how to protect yourself and you know, be aware of what you can do 
to yourself.  And how easy it is to get, and it is a permanent thing.” 
 
“I do think people mostly feel like, yeah, I kind of know how it [HIV] is passed, 
and Hep C is really the one that we don‟t know.” 
 
 
Taking it to Treatment Court Encouraged Abstaining from Drugs 
Participants felt TITTC provided some motivation to engage in protective behaviors 
related to abstaining from drugs.  Participants mentioned TITTC was an incentive to 
abstain and offered ways in which the knowledge from the intervention has impacted 
their thinking.  One participant mentioned a time when she relapsed and how she kept 
reminding herself of the information she learned from the intervention. 
“It was an incentive [to abstain].” 
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“More reasons to think about not doing it [use drugs].” 
“It may have, it have done it [made me feel more confident to abstain from drug 
use] in the fast line of…of, actually catching the disease, that you can catch from 
using drugs.  Opposed to, oh well, I‟ll never catch this [HIV or HCV].  You know 
what I mean?  Kind of got the education on it, so you are more likely to think 
about it, instead of just being like, oh, it‟s never been something I had to worry 
about now, so let‟s not even think about it.” 
 
“It is scary to just, to realize how many times I put myself in a situation where I 
could have gotten it [HIV or HCV].” 
 
“You thought twice before you stuck a needle in your arm that you thought was 
dirty.” 
 
“It was like, when I relapsed it was always in the back of my head about like 
passing a loker [glass pipe used to smoke meth] around because the chapped lips.  
It dehydrates you and that pipe, when you pass it around, you know, you can get it 
that way because, it was always in the back of my head.” 
 
 
Participants Respected and Trusted the Outreach Workers 
Focus group participants thought very highly of the outreach workers who conduct 
TITTC. They were described as being knowledgeable, sincere, honest, relatable, 
personal, funny, supportive, passionate, compassionate, easy to understand, comforting 
and helpful.  Participants were willing to listen to the outreach workers because they were 
indigenous to the population which allowed the outreach workers to build trust and 
rapport.  Participants of the focus group also talked about whether or not the intervention 
would work if different outreach workers conducted TITTC.  In general participants felt 
any outreach worker would need to be similar in lifestyle, attitude, passion and 
experience as the outreach workers who conduct this intervention.  Participants 
mentioned if the outreach workers were not indigenous to the population they would be 
less respected, effective, or trusted. 
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“I think their personalities bring a lot to it and makes you want to actually, to 
listen and pay attention.”         
 
“[T]hey make you laugh, and I mean they make you comfortable.” 
 
“It might be the same if you had other people that were like, like them.  You know, 
had that like you know attitude.” 
 
“People that have lived our life and know what that‟s like, it might have the same 
effect.” 
 
“[I] think that part of it for me was just that they really make you want to pay 
attention [be]cause they are interesting and they relate, you know, you can relate 
to them, and I don‟t know.  You know, maybe if someone comes in with text book 
knowledge of it, I would be bored to tears.” 
 
“It would only be a good program on its own if there was two people involved 
that had the history and the stories to back up the program.  Because you have 
two people that don‟t have anything to do with what you‟re teaching, nobody 
wants to pay attention to those people because they don‟t, they don‟t have 
firsthand experience…You want firsthand experience if you are being taught 
something honest.” 
 
“They are genuine, they‟re like us.  It‟s not just like they are just doing it for the 
paycheck…” 
 
“[It] has to be someone who want to do that [teach an intervention].  I mean the 
reason that it is so effective is because they [the outreach workers] are interested 
in it.” 
 
“I mean, I think the way they have it set up is great and I don‟t know how you 
could improve upon that, and that‟s just kind of, I think that if you had two 
different people in there and they did it the same way it might not work as well.  I 
think it‟s just that you got the two right people doing the right thing.” 
 
“It makes me feel more secure [to know the outreach workers are available when 
you need them].  I mean, you really could call them.” 
 
“I thought it was very important [the outreach workers offered follow up 
support].  Very important.  And anytime that I have seen her [outreach worker], 
like at Drug Court when she is there, or whatever, there is so much support from 
them about anytime contact me, you know.  Her little card that she hands out, you 
know.” 
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Taking it to Treatment Court:  Urinalysis and Arrest Reports 
Participants were asked 11 self report questions at the end of the Theory of Planned 
Behavior survey.  The results of their answers to the drug use history and arrest report 
questions are examined below.  The responses given by the participant were compared to 
actual Urinalysis (UA) and arrest report data supplied to the researchers by the YCFDTC 
coordinator and compared to scores on the TPB survey.  Researchers were looking for 
correlations between intentions to abstain from drugs and actually abstaining.  Each week 
participants of YCFDTC are remanded to UA screening.  The results of these tests are 
placed in the client’s permanent file along with any records of recent arrests (Roche, 
2008).  Researchers obtained this information through the use of unique identifiers to 
maintain anonymity of participants.  The YCFDTC Coordinator matched the names of 
the client to their unique identifier supplied on the study survey.  Results were obtained 
via email. 
One of the self report questions asked participants to write in their primary drugs 
of choice prior to entering YCFDTC.  All ten participants responded.  The results are 
based off the pre test survey data and were as follows: 
 Alcohol (n=9) 
 Marijuana (n=7) 
 Methamphetamine (n=1) 
 Opiates (n=2) 
 Prescription drugs (n=3) 
The total for drugs used exceeds ten as participants indicated more than one drug of 
choice. 
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Participants of this study were asked to recall how many times in the three months 
prior to YCFDTC they used drugs and/or injection drugs and how many times they had 
used drugs and/or injection drugs in the past three months prior to TITTC.  Responses to 
the drug use frequency questions were answered by checking one of four boxes: daily; 
weekly (1-2 times/week); monthly (1-2 times/month); or never.  The following tables 
show the frequencies of answers given.  The three month follow up posttest results 
represent the five participants with complete data sets. 
 
Table 15.  Self Report Frequencies of Drug Use Pretest 
Frequencies of Drug Use Prior to YCFDTC and Past 3 
Prior to TITTC:  Pretest 
  DU Prior 
YCFDTC 
 
IDU Prior 
YCFDTC 
DU Past 3 
Months 
IDU Past 3 
Months 
Daily 8 1 1 0 
Weekly 1 1 1 0 
Monthly   0 2 1 0 
Never 0 6 7 10 
 
 
Table 16.  Self Report Frequencies of Drug Use Three Month Follow Up Posttest 
Frequencies of Drug Use Prior to YCFDTC and Past 3 
Months:  Three Month Post Test 
  DU Prior 
YCFDTC 
 
IDU Prior 
YCFDTC 
DU Past 3 
Months 
IDU Past 3 
Months 
Daily 3 1 0 0 
Weekly 1 0 0 0 
Monthly   0 1 0 0 
Never 1 3 5 5 
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Participants were asked an open ended question in regards to arrest history.  They 
were to write in any charges they had incurred during the past three months.  One 
participant indicated he/she had been arrested for a felony drug charge, three driving 
under the influences, one fleeing and eluding, and stealing a car.  Another participant 
indicated he/she had been arrested for possession of drug paraphernalia and an 
outstanding warrant.  All other participants indicated this question was not applicable or 
they had no arrests.   
Participants’ UA and arrest records were obtained from three months prior 
TITTC, to three months post TITTC.  The results of this data were compared to overall 
intentions to abstain from drug use scores on the TPB survey.  Researchers were looking 
for correlations between intentions to abstain from drugs and actually abstaining based on 
UA data.  The following graphs plot the overall behavioral intention to abstain from 
drugs score with the total number of positive UAs for each participant.  A positive UA 
indicates the presence of drugs in the urine.  The two week posttest survey data was not 
included in this analysis.  The data only includes the five participants with complete data 
sets, as these were the only participants that complete UA data was made available.  
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Figure 2.  Pretest Drug Use Survey Scores and positive UAs.  
 
  
Of the five participants included in this data set above, the two participants that 
self-reported no drug use in the past three months had positive UAs.  The other three 
participants that self-reported they used drugs in the past three months did not have 
positive UA results.  A correlation co-efficient was run using Microsoft Excel.  There 
was not a correlation between pretest drug use scores and positive UA results (r²=0.002). 
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Figure 3.  Three Month Follow up Drug Use Survey Scores and Positive    
                  UAs.   
 
 
 
 
Of the five participants included in this data set above, three participants self-
reported they never used drugs in the past three months, which was confirmed by the UA 
results.  The other two participants self-reported they never used drugs in the past three 
months, and both of these individuals had positive UA results.  A correlation coefficient 
was run using Microsoft Excel.  There was not a correlation between three month posttest 
drug use scores and positive UA results (r²=0.059). 
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CHAPTER V 
Discussion 
 
The purpose of this study was to evaluate the HIV/HCV prevention intervention, Taking 
it to Treatment Court. This evaluation examined whether the program (1) increased 
participants’ knowledge about HIV/HCV risk reduction behaviors and (2) if their 
intention to abstain from drug use and/or practice safer sex was affected.  Analysis of 
results from the TPB Questionnaire, the HIV and HCV Knowledge Questionnaire, and 
focus group interviews are discussed below. 
 
Intentions to Abstain from Drug Use 
There was overall statistically significant short term gains in intention to abstain from 
drug use based on the Theory of Planned Behavior Drug Use Survey between the pre and 
two week posttests when examining total scores.  Long term gains in intention to abstain 
from drug use were not seen from the pre to three month follow up surveys when 
examining the five participants with complete data sets.     
   In analyzing each subsection of the TPB Drug Use Survey the attitude subsection 
was the only section found to have short term statistical significance.  The significant 
gains in attitudinal scores from pre to posttest may be a result of increased knowledge 
about the dangers of HCV when using drugs.  Attitudes toward a behavior are based on 
behavioral beliefs toward the action (If I use drugs I am at high risk for HCV) and an 
evaluation of the outcomes associated with the behavior (HCV can be a deadly disease) 
(Montano et al., 1997).  Focus group participants mentioned TITTC focused more on 
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knowledge about HIV and HCV then on support to abstain from drugs, which may be 
why statistically significant gains were not found for normative beliefs.    
 Statistically significant gains were not found in the Normative Belief, Control and 
Direct Measures sub scales from pre to posttest.  While the lack of statistical significant 
may indicate that the intervention had little effect on normative beliefs and perceptions of 
control, it is important to note that the lack of significance also may be related to the 
small sample size or too few questions related to each subscale. Despite the lack of 
statistical significance, means scores did increase from pre to posttest.  
 Whether or not TITTC improved normative and control beliefs directly cannot be 
determined.  Participants came into TITTC with high normative beliefs towards 
abstaining from drugs which may be a result of a strong sense of support from the 
YCFDTC and this support may have increased over time.  Control beliefs were also high 
at pretest and continued to increase over time.  Control beliefs may have increased over 
time as a result of abstaining from drugs for longer periods of time.  Participants may be 
gaining skills from other YCFDTC programs that allow them to feel more in control 
towards abstaining from drugs.      
The YCFDTC is designed to encourage participants to abstain from drugs through 
the use rewards and sanctions, and ultimately reunification with their children (Roche, 
2008).  Overtime, it would be expected that participants’ intentions to abstain from drug 
use would increase as the incentives become greater.  It is hard to definitively conclude 
that the intentions to abstain from drug use are a result of TITTC independently.  
However, based on the pretest/posttest results it would appear that TITTC may have 
contributed to YCFDTC participants’ gains in intentions to abstain from drug use.  
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 Intentions to Practice Safer Sex 
Long and short term gains in intention to practice safer sex were not statistically 
significant.  This lack of statistical significant may indicate that the intervention had little 
effect on intentions to change risky sexual behavior, or the lack of significance may be 
related to the small sample size or to measurement error.  Ambivalence about intentions 
to practice safer sex, as indicated by the pretest scores, could have contributed to the lack 
of statistically significant findings.  It may also be that a six hour intervention was not 
long enough to encourage long lasting behavioral change. Research indicates that 
effective behavioral interventions usually last between 9 and 18 hours and involve more 
than one meeting (Lyles et al., 2007).  This supposition is supported by the fact that 
changes in attitudes toward drug use, which were reinforced everyday as part of the 
YCFDTC, were found to be statistically significant, while changes in attitudes toward 
safer sex that were encouraged only during the six hour TITTC program were not.    
It is important to note that although there was no statistically significance change 
from pre to posttest, means scores did increase over time. This increase in scores from 
pre to posttest is supported by comments from focus group participants who indicated 
TITTC did a good job of offering free condoms and lube, encouraging safer sex practices, 
and condom negotiation.  
 
HIV Knowledge 
The results of the paired samples t test showed the short term and long term gains in HIV 
knowledge were not significant from pre to posttest.  This lack of significance may be 
due, in part, to the high pretest scores.  The pretest scores indicated that participants had a 
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good understanding of HIV prevention and transmission before participating in TITTC.   
Since HIV has been the focus of prevention efforts for 17 years (Kops, 2010) high pretest 
scores may be indicative of the effectiveness of these prevention efforts.   
Despite the high scores on the HIV knowledge questionnaire, analysis of 
individual questions reveals areas that would benefit from more emphasis.  Many 
participants incorrectly answered questions on the posttest and three month follow up 
tests related to the types of body fluids that transmit the virus.  Many also were unaware 
of behaviors that put them at risk for HIV as well as being unaware of the effects of 
antiretroviral drugs on transmission risk. 
Results from the focus group interviews tended to reinforce the results from the 
HIV knowledge questionnaire.  Most participants indicated TITTC was a good refresher 
of information on HIV and cleared up any myths they believed in regards to HIV 
transmission and prevention.  However, outside of the current epidemiologic information 
presented, none of the focus group participants stated that the HIV knowledge provided 
was new material. Overall, this may indicate that less time needs to be spent on general 
information about HIV during interventions.  Instead, intervention specialists may want 
to focus on common myths or misunderstandings about HIV/AIDS transmission and 
prevention.   
 
HCV Knowledge 
Participants in TITTC showed significant short term gains in HCV knowledge scores 
from pre to two week post evaluations.  Long term gains in HCV knowledge were upheld 
from pretest to three month follow up when analyzing the five participants with complete 
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data sets.  Pretest scores on the HCV Knowledge Questionnaire were much lower on 
average than pretest scores on the HIV Knowledge Questionnaire.  This is not surprising 
given that HIV has been the focus of prevention efforts for the past 17 years, while HCV 
prevention has received minimal funding and little attention in the state of Montana 
(Kops, 2010) or nationally (Edlin, 2002).   
Results of the focus groups reinforced the findings from the HCV questionnaire. 
The majority of participants indicated they had little to no prior knowledge about HCV 
before TITTC.  Most participants indicated the education about HCV in TITTC was 
valuable and necessary.  Despite the significant gains in knowledge from pre to posttest 
on the HCV questionnaire, there were several questions many participants answered 
incorrectly on both the pretest and the posttest.  Questions most frequently missed were 
those related to: the prevalence of HCV; knowledge about symptoms of acute and 
chronic HCV; and modes of transmission.  Emphasis on these topics may encourage 
uninfected individuals to avoid behaviors that put them at risk for infection, as well as 
encourage those infected with HCV to recognize symptoms, seek treatment, and avoid 
further disease transmission.     
The effects of the intervention on HCV knowledge and behavior are further 
reinforced by the findings from the question regarding HCV testing.  Prior to TITTC, 
only five participants had been tested for HCV.   Two weeks post intervention nine 
participants had been tested.  This may indicate that TITTC was an incentive for HCV 
testing.  Offering this service as part of TITTC may ensure all participants are tested in 
the future. 
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Perceptions of Taking it to Treatment Court 
The general impressions based on the focus group data were Taking it to Treatment Court 
offered more in the way of knowledge than encouraging abstinence from drug use or 
practicing safer sex.  Participants mentioned they felt encouraged by the outreach 
workers to engage in these behaviors, but more emphasis was placed on the intervention 
educating clients about the risks of HIV and HCV.  
 Many of the comments provided during the focus groups were validated by the 
TITTC Evaluation Survey results.  Participants mentioned the intervention taught them 
more about HCV than HIV, and the survey data showed significant gains in HCV 
knowledge, but not HIV knowledge.  The gains in knowledge may be why a short term 
change in attitudes toward drug use was found.        
 Studies have tried to capture what makes an HIV intervention effective.  Lyles et al. 
(2007), in a meta-analysis of 100 behavioral interventions, describes the qualities of an 
effective HIV prevention intervention.  The qualities of effective interventions identified 
in the meta- analysis that TITTC meet are:   
 the intervention is based on behavioral theory, 
 the intervention encourages social or group support,  
 the intervention is facilitated by an individual that is indigenous to the target 
population, 
 the intervention helps participants develop plans or set goals for risk reduction, 
 the intervention includes technical, personal and interpersonal skill-building 
components, and 
 the intervention utilizes a variety of delivery methods:  
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 Discussion 
 Demonstration 
 Lecture/Instruction 
 Role play (Lyles et al., 2007).  
While these qualities are satisfied by TITTC and were mentioned by participants of the 
focus groups, some important qualities are missing.  Important qualities missing from 
TITTC include: 
 9-18 hours of intervention time over more than one session, 
  stress reduction and management skill building, and 
 identification and management of triggers for risky sexual behaviors. 
 
The interventions examined by Lyles et al. (2007) which contained these components 
saw significant gains in condoms use, reduced number of sexual partners, reduced 
incidence of sexually transmitted infections, and reduced IDU or needle sharing at three 
to twelve month follow ups.  These behaviors would not only protect against HIV 
transmission, but HCV transmission as well.  By following more of these 
recommendations from Lyles et al. (2007), TITTC may become a more effective 
behavioral intervention to minimize risky sexual and drug use behaviors.     
 
Urinalysis and Arrest Report Correlation 
Data collected from the YCFDTC coordinator indicated that no participants were arrested 
during the study time.  Two participants indicated they had been arrested, however the 
arrests specified may have occurred before the time of the study and so were not relevant. 
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 Urinalysis data showed positive UA results for three of the five participants with 
complete data sets.  The self-report and UA data did not match for any of the pretest 
surveys; participants either checked they never used drugs and did, or checked they used 
drugs but had negative test results.  For the three month posttest data, three participants 
self report answers matched the UA data and two participants indicated they never used 
drugs but had positive test results.  There was no correlation between any of this data.  
The lack of correlation may be a result of small sample size, participants offering socially 
desirable answers, or high behavioral intentions not resulting in direct behavioral change 
immediately. 
 
Limitations 
Limitations exist within all study designs that may impact the results.  There were many 
limitations within this study that could have impacted the data collected.  The following 
is an examination of the limitations.   
This study was limited to a small sample size.  Eleven participants entered the 
study, ten completed the two week follow up, and five completed the three month follow 
up.  The participant that dropped out of the study was terminated from the YCFDTC and 
so was unable to complete the study.  While the sample size was small, the ten 
participants comprised the total population of clients in YCFDTC during the time of the 
study.  However, only five of the ten participants completed all three data points, 
resulting in a less than desirable sample size and only half the total population.    
Clients of YCFDTC are required to attend weekly hearings with the drug court 
judge, counseling sessions, and other courses and groups throughout the 12 to 18 months 
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they are enrolled in the program.  Taking it to Treatment Court is only one six hour 
intervention offered to these clients.  It is however, the only intervention that provides 
information on HIV and HCV prevention.  While the gains in HCV knowledge may be 
attributed to TITTC, it is difficult to discern if changes in intention to abstain from drugs 
were the result of participation in TITTC or a combination of many factors related to 
participation in YCFDTC.  Had this study utilized a control group, more definitive 
conclusions could have been drawn.  However, given the small sample size and the 
difficulty of recruiting a comparable control group, this was not a feasible option. 
Focus group data was limited to the participants who attended the meetings.  
Approximately 15 participants were recruited, however only ten showed up.  The ten 
participants who attended the focus groups may represent a group of individuals with 
similar ideals and values based on their willingness to participate and follow through with 
their commitment.  There were also dominant participants in both focus groups.  The 
quotes selected may only reflect the opinions and attitudes of these few individuals rather 
than the entire group.  Dominant participants may have discouraged other participants 
from getting involved as well, which might have resulted in an omission of other 
important attitudes and opinions of TITTC. 
The focus groups were conducted by two researchers from the University of 
Montana.  The drug court coordinator was present before and after each focus group, but 
was not part of the dialogue.  The presence of two individuals who are not indigenous to 
the population may have discouraged participants from disclosing too much information. 
The participants may not have trusted the researchers, or gave socially desirable answers 
to protect themselves and the outreach workers they were evaluating.  Participants of 
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YCFDTC may have also worried of disclosing incriminating information which could 
result in program sanctions, losing child custody, or being arrested, regardless of 
confidentiality being established.        
 
Recommendations 
The population examined in this study appears to have a solid foundation for HIV 
knowledge, and less of an understanding of HCV.  It would be beneficial to continue to 
incorporate HCV education for drug use interventions, as injection drug use is the 
primary route of transmission for this virus (CDC:  Hepatitis, 2008).  Offering sterile 
injection equipment or information on where such equipment could be obtained may also 
result in a reduction in HCV transmission (Edlin, 2002) as well as encouraging safer drug 
use practices should relapse occur.  TITTC’s effectiveness may also benefit from 
focusing more heavily on misconceptions, myths, sexual transmission and condom use 
for HIV amongst this population, as injection drug transmissions rates are low and sexual 
transmission remains a primary route of exposure (Booth et al., 2000).  Many participants 
missed questions pertaining to these topics on the pre and posttest survey as well.   
It would also be advisable to increase the length and number of sessions of the 
intervention to match the recommendations from Lyles et al. (2007).  This would allow 
additional time to incorporate more of the elements of an effective HIV intervention. 
TITTC appeared to have had a greater effect on factors related to HCV rather than HIV 
prevention, so lengthening the intervention and emphasizing the difference in 
transmission modes between HIV and HCV may be useful for future interventions.  For 
example, one or two sessions could focus on HCV and intentions to abstain from drugs 
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and one or two sessions could focus on HIV and intentions to practice safer sex.  This 
distinction might help participants understand that while HIV and HCV are both diseases 
that afflict persons who use drugs, their primary modes of transmission are dramatically 
different.  While it is possible to transmit HCV sexually, the rate of sexual transmission is 
minimal.  HIV can be transmitted via injection drug use; however sexual transmission is 
the primary route of infection for this virus (Booth et al., 2000).  Furthermore, individuals 
who take the necessary precautions to protect themselves from HCV when injecting 
drugs would also ensure protection from HIV (Edlin et al., 2005; Hahn et al, 2002).  This 
has been seen in needle exchange programs where HIV and HCV incidences decrease 
overtime (Edlin et al., 2005).    In the end, separating information base on primary modes 
of transmission may reduce confusion about disease transmission and risks.     
Finally, TITTC may benefit from offering on site testing to ensure all participants 
know their disease status which may contribute to a reduction in disease transmission.  
While this study found increases in the total number of participants tested for HCV from 
pre to posttest, there was still one individual who was not tested through the three month 
follow up.   Individuals who test positive for HIV and/or HCV can also seek out medical 
attention and counseling as needed.        
 
Conclusions  
The data collected during this research was used to determine the effectiveness of Taking 
it to Treatment Court.  While the small sample size limited the researchers ability to draw 
definitive conclusions based on statistical tests, several findings appear to have practical 
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significance for prevention specialists who work with individuals who use injection 
drugs.      
One of the most important finding in this study may be the dramatic difference 
between participants’ gains in knowledge about HCV versus gains in knowledge about 
HIV.  HCV has not been the primary focus of prevention efforts targeted toward drug 
users and as a result transmission and prevalence rates are alarmingly high among 
persons who use injection drugs (Edlin, 2002).  It is not surprising then that participants’ 
scores on the Hepatitis C Knowledge Questionnaire at baseline were low and that focus 
group results validated participants’ lack of knowledge about HCV.  The positive effects 
of the intervention can be clearly seen in the two week posttest and three month follow-
up results from this study wherein participants made significant gains in knowledge about 
HCV transmission and prevention.  In addition, the effects of the intervention on HCV 
are reinforced by the increase number of participants who were tested for HCV from 
pretest to two week posttest.   Both these finding strengthens the argument by Edlin 
(2002) that more emphasis needs to be placed on HCV prevention for persons who use 
drugs.   
On the other hand, HIV prevention has been the focus of prevention efforts in 
Montana for nearly two decades (Kops, 2010) and may be the reason baseline scores on 
the HIV Knowledge Questionnaire were high.  Because of the high initial scores, no 
increase in knowledge was found on either the two week posttest or the three month 
follow-up test.  This may indicate that relative to HCV less intervention time needs to be 
spent on information on HIV.   
93 
 
A second important finding in this study was the statistically significant increase 
in intentions to abstain from drug use from pretest to two week posttest.  This increase 
may be, in part, a result of increased knowledge about HCV.  Knowing the dangers of 
HCV may have provided the participants further incentive to abstain from drugs.  It is 
also highly probable that increased intention to abstain from drug use was a result of the 
combined effects of YFDTC’s and TITTC’s focus on abstinence from drug use.  It was 
not possible to separate the effects of participants’ overall involvement in the day to day 
activities of drug treatment court from the effects of the six hour TITTC intervention. 
However, it is likely that both programs contributed to the short term statistically 
significant change in intentions to abstain from drug use. 
A third important finding in this study was that intentions to practice safer sex 
were not significantly changed over time.  Overall, TPB Safer Sex scores were mixed 
prior to the intervention indicating participants had mixed feeling about intentions to 
practice safer sex and mixed attitudinal, normative, and control beliefs towards the 
behavior.  Despite the ambivalence of some of the survey participants about practicing 
safer sex, focus groups participants reported that the outreach workers did a good job of 
handing out condoms and lube and encouraging safer sex.  Gains may not have been seen 
because the intervention may not have been long enough to effect changes in sexual 
practices.   
    Finally, it is important to recognize that despite the small sample size 
statistically significant increases over time were found in HCV knowledge and in 
intentions to abstain from drug use.  Given that this intervention may have been effective 
at increasing HCV knowledge, may have contributed to participants gains in intentions to 
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abstain from drugs and is perceived in a positive light by individual participants, it may 
be worthwhile to consider expanding it to other treatment courts where HIV/HCV 
education and prevention are woefully absent and where evaluation efforts can be 
expanded to include a comparison of individuals who participate in TITTC and those 
who do not participate.     
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Appendix A 
 
Elicitation Interview Survey 
 
 
a 
 
THEORY OF PLANNED BEHAVIOR:   ELICITATION INTERVIEWS 
 
 recovering user  
  
 current user/ 
intention to stop
     
 current user/no 
intention to stop 
DRUG USE 
Behavioral Outcomes of Drug Use 
 
1. What do you believe are the positive aspects of drug use? 
 
2. What do you believe are the negative aspects of drug use? 
 
3.    Is there anything else you associate with drug use? 
 
Normative Referents for Drug Use 
 
1. Are there any individuals or groups who would approve of your drug use? 
 
2. Are there any individuals or groups who would disapprove of your drug use? 
 
3. Are there any other individuals or groups who come to mind when you think about 
drug use?  
 
Control Factors for Drug Use 
 
1. What factors or circumstances would enable you to stop using drugs? 
 
2. What factors or circumstances would make it difficult or impossible for you to stop 
using drugs? 
 
3. Are there any other issues that come to mind when you think about the difficulty of 
not using drugs? 
 
 
 
 Practicing safer sex  Not Practicing safer sex 
 
 
SAFER SEX 
Behavioral Outcomes of Safer Sex 
 
1. What do you feel are the advantages of safer sex, i.e. male/female condom use? 
 
2. What do you feel are the disadvantages of safer sex? 
 
3. Is there anything else you associate with safer sex? 
 
Normative Referents for Safer Sex 
 
1. Are there any groups or individuals who would approve of you having safer sex? 
 
2. Are there any groups or individuals who would disapprove of you having safer 
sex? 
 
3. Are there any other individuals or groups who come to mind when you think 
about safer sex? 
 
Control Factors for Safer Sex 
 
1. What factors or circumstances would enable you to practice safer sex? 
 
2. What factors or circumstances would make it difficult or impossible to practice 
safer sex? 
 
3. Are there any other factors that come to mind when you think about the 
difficulty of practicing safer sex?
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Taking it to Treatment Court: 
 Evaluation Survey  
Instructions: 
Please read each question 
thoroughly and answer to the 
best of your ability.  Do not 
spend much time answering each 
question; generally your first 
thought is the best answer.   
 
Your identity will be completely protected and the 
answers you provide will not be used against you in any 
way.  Absolutely do not write your name anywhere on 
this survey.   
 
If at any time you decide you are not comfortable with a 
question or completing the survey please do not hesitate 
to leave the question blank or stop filling out the survey. 
 
Thank you very much.  Your time is greatly appreciated!. 
Code Number 
Please circle the month you were born: 
Jan.     Feb.    March     April     May      June     July     Aug.   Sept.     Oct.     Nov.    Dec. 
AND Write the first three letters of your mother’s first name: ___________ 
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1. Age: _____ years 
 
2.  Biological Sex (sex at birth): 
 Male    Female  
3. What is your sexual orientation? 
       Heterosexual/straight                           Bisexual                                                                     
       Homosexual/gay or lesbian               Unsure  
4.  What is your relationship status?   
 Single   
 Married 
 Divorced 
 Separated 
 Widowed 
 Living with a partner/not 
married 
 
5.  How many children do you have?    
 1  2  3  4  5  6   7+ 
6. What is the highest level of education you have completed? 
 Less then high school                Some college 
 High school graduate/GED               College graduate 
 Trade vocational school               Graduate/Professional school 
7. Prior to treatment had you been tested for? (circle one) 
 HIV:           Yes         No            
Hepatitis C:         Yes        No  
8. Are you employed or do you have other regular income? 
 Yes     No 
 
      9.  Which of the following represents your individual yearly income? 
           (The amount you would claim on your income tax forms.) 
 
< 6,000             35,001 - 50,000 
 6,000 - 10,000           50,001 - 75,000 
10,001 - 20,000           75,001 -100,000 
 20,001 – 35,000                        100,000+ 
Section 1:  Demographics 
d 
 
      10.   With which of the following do you identify? 
   White (non-Hispanic) 
   American Indian/Alaska Native 
 Black/African American (non-Hispanic) 
 Hispanic/Latino/Chicano 
 Asian/Pacific American 
 Bi-racial or multi-racial/ethnic (Please specify) _______________ 
 Other (Please specify) _____________________ 
 
 
 
 
Section 2:  Drug Use and Safer Sex Survey 
 
Sample Question 
The questions in this survey use a seven point scale to rank each item. Please mark 
the position on the scale you feel best fits your opinion.  For example, the question 
may ask you to rank the following statement: 
 
Summer is my favorite season of year. 
Agree _  1  _ : _  2  _ : _  3  _ : _  4  _ : _  5  _ Disagree 
                                    Extremely    Agree      Neither     Disagree      Extremely 
If you extremely agree that summer is your favorite season, then you mark an X 
where the number one would be. 
 
Summer is my favorite season of the year 
Agree _  X  _ : _     _ : _     _ : _     _ : _     _ Disagree 
 
If you feel summer is neither your favorite, nor least favorite season of the year, 
then you mark an X where the number four would be. 
 
Summer is my favorite season of the year 
Agree _     _ : _     _ : _   X  _ : _     _ : _     _ Disagree 
 
In marking your ratings, please remember the following points: 
 Be sure to answers all items 
 Never supply more than one answer for any one question. 
 
Some of the questions may appear to be asking the same thing, however they are 
asking somewhat different issues. Please read the questions carefully before 
marking your answer. 
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Each question in the section below refers to your PAST DRUG USE 
1. Drug use is a way for me to escape from my problems 
                                             Strongly agree___  ___   ___  ___  ___ Strongly disagree 
2. If I stop using drugs my friendships with people who use drugs will end  
                                          Extremely likely___  ___   ___  ___  ___ Extremely unlikely 
3. Drug use leads to ________  relationships with my family   
                                                    Very good___  ___  ___  ___  ___ Very poor 
4. I will get my kids back if I stop using drugs   
                                             Strongly agree___   ___  ___  ___  ___ Strongly disagree 
5. Going to jail  because of my drug use is   
                                           Extremely likely___  ___  ___  ___  ___ Extremely Unlikely 
6. My health is __________ when I use drugs   
                                                    Very poor___  ___  ___  ___  ___ Very good 
7. I have lost touch with reality because of drug use    
                                      Strongly disagree ___  ___  ___  ___  ___ Strongly agree 
8. Drugs have made it_______ for me to hold a steady job   
                                         Extremely likely ___  ___  ___  ___  ___ Extremely Unlikely 
9. Overall, I think drug use is              
                                                       Harmful ___  ___  ___  ___  ___ Beneficial   
                                                      Pleasant ___  ___  ___  ___  ___ Unpleasant   
                                                    Enjoyable ___  ___  ___  ___  ___Not enjoyable  
                                              Easy to avoid ___  ___  ___  ___  ___ Difficult to avoid 
10. Using drugs increases my risk for HIV 
                                         Extremely likely ___  ___  ___  ___  ___ Extremely Unlikely 
11. Using drugs increases my risk for Hepatitis C 
                                         Extremely likely ___   ___  ___  ___  ___ Extremely Unlikely 
12. Escaping from my problems through drug use is 
                           Extremely Undesirable ___   ___  ___  ___  ___ Extremely Desirable 
13. Maintaining my friendships with friends who use drugs is 
                          Extremely Undesirable ___  ___  ___  ___  ___ Extremely Desirable 
14. Maintaining positive relationships with my family 
                          Extremely Undesirable ___  ___   ___  ___  ___ Extremely Desirable 
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15. Getting my kids back is 
                               Extremely Desirable ___   ___  ___  ___  ___ Extremely Undesirable 
16. Going to jail is 
                          Extremely Undesirable ___  ___   ___  ___  ___ Extremely Desirable 
17. Maintaining good health is 
                          Extremely Undesirable ___  ___  ___  ___  ___ Extremely Desirable 
18. Losing touch with reality is  
                              Extremely desirable ___  ___  ___  ___  ___ Extremely Undesirable 
19. Maintaining a steady job 
                         Extremely Undesirable ___  ___  ___   ___  ___ Extremely Desirable 
20. Decreasing my risk for/spreading of HIV by not using drugs is 
                         Extremely Undesirable ___  ___  ___  ___  ___ Extremely Desirable 
21. Decreasing my risk for/spreading of Hepatitis C by not using drugs is 
                               Extremely Desirable ___  ___ ___  ___  ___ Extremely Undesirable 
22. My using friends think that I _______________use drugs 
                                               Should ___  ___  ___  ___  ___ Should not 
23. My parents and siblings think that I  _______________use drugs 
                                               Should ___  ___ ___  ___  ___ Should not 
24. My child/children think that I _________________use drugs 
                                               Should ___  ___  ___  ___  ___ Should not 
25. The Yellowstone Family Treatment Drug Court thinks that I ________________use drugs 
                                                Should ___  ___  ___  ___  ___ Should not 
26. My using friends’ opinions on my drug use are important to me 
                                                  Extremely ___  ___  ___  ___  ___ Not at all 
27. My parent’s and sibling’s opinions on my drug use are important to me 
                                                  Extremely ___  ___  ___   ___  ___ Not at all 
28. My child’s/children’s opinions on my drug use are important to me 
                                                  Extremely ___  ___  ___  ___  ___ Not at all 
29. The Yellowstone Family Treatment Drug Court’s opinions on my drug use are important to 
me 
                                                 Extremely ___  ___  ___   ___  ___ Not at all 
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30. I lack the knowledge of how to stop using drugs 
                                  Strongly agree ___  ___   ___  ___  ___    Strongly disagree 
31. The threat of going to jail/prison is enough to keep me from using drugs 
                                                   Disagree  ___  ___  ___   ___  ___  Agree 
32. When I am depressed or lonely I am______________ to use drugs 
                                                     Unlikely ___   ___  ___  ___  ___  Likely 
33. I will have to find new friends that do not use drugs 
                                                     Unlikely ___  ___   ___  ___  ___ Likely 
34. Running into using friends tempts me to use again 
                                                  Very much so ___  ___  ___  ___  ___  Not at all 
35. When my kids are around I use drugs 
                                                  Unlikely  ___  ___  ___  ___  ___   Likely 
36. Being around drugs tempts me to use  
                                 Strongly agree___  ___   ___  ___  ___  Strongly disagree 
37. I have used drugs to cope with stress 
                                                   Unlikely ___  ___  ___   ___  ___  Likely 
38. I am able to find a job 
                                                        Likely ___  ___   ___  ___  ___  Unlikely 
39. My family relationships fell apart because of my drug use 
                                                  Unlikely  ___  ___  ___   ___  ___  Likely 
40. Having the knowledge on how to stop using drugs would make it ________that I would 
stop using  
                                                 Less likely ___  ___   ___  ___  ___  More likely 
41. I will not go to jail/prison because of my drug use 
                                                                  Agree ___  ___  ___  ___  ___   Disagree 
42. I can cope with depression or loneliness without turning to drugs 
                                                      Unlikely ___  ___  ___  ___  ___  Likely 
43. It is _______ that I will find new friends that do not use drugs 
                                Extremely likely___  ___  ___  ___  ___ Extremely unlikely 
44. I can run into using friends and control my urges to use 
                                       Extremely likely ___  ___  ___   ___  ___  Extremely unlikely 
45. It is _____________ that I will use again if I do not get my kids back 
                                        Extremely likely___  ___  ___  ___  ___  Extremely unlikely 
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46. I can be around drugs and not use  
                                        Extremely likely___  ___  ___   ___  ___ Extremely unlikely 
47. Feeling stressed would make it ________  that I would use drugs to cope 
                                               Extremely likely ___  ___  ___   ___  ___ Extremely unlikely 
48. Having a job makes it _______ to stay off drugs 
                                         Much more difficult ___   ___  ___  ___  ___  Much easier 
49. I am _________ to stay clean if my regain my relationships with my family 
                                                     Less likely___  ___  ___  ___  ___ More likely 
50. Changing my entire lifestyle to stay clean will be  
                             Very undesirable ___   ___  ___  ___  ___ Very desirable 
                               Extremely likely ___  ___  ___  ___  ___ Extremely unlikely 
                                             Beneficial ___  ___  ___  ___  ___ Harmful 
                                                      Good ___  ___  ___  ___  ___ Bad 
Each question in this section refers to you practicing safer sex. 
Safer sex is defined as using a condom. 
51.  Using a condom does not feel good 
                                             Strongly agree ___  ___  ___  ___  ___   Strongly disagree 
52. I will lose the trust of my partner if I decide we should use condoms 
                                              Strongly agree ___  ___  ___   ___  ___  Strongly disagree 
53. Being with a partner for a long time reduces the need to use condoms 
                                              Strongly agree___  ___  ___  ___  ___ Strongly disagree    
54. Using condoms reduces my risk for HIV and other Sexually Transmitted Diseases (STDs) 
                                              Strongly agree ___  ___  ___  ___  ___   Strongly disagree 
55. Using condoms reduces my risk for Hepatitis C 
                                       Strongly agree ___  ___  ___  ___   ___  Strongly disagree 
56. Using a condoms inconvenient  
                                       Strongly agree ___  ___   ___  ___  ___  Strongly disagree 
57. Condoms are too expensive  
                                              Strongly agree ___  ___  ___  ___  ___  Strongly disagree 
58. Having sex without a condom with a casual partner is too risky 
                                       Strongly agree ___  ___  ___  ___  ___  Strongly disagree 
59. Having sex without a condom  is  _________________ sex with a condom 
                                    More desirable  ___  ___  ___  ___  ___   Less desirable 
 
i 
 
 
60. Maintaining the trust of my partner is _________________ than asking my partner to use 
a condom 
                                  More important ___  ___  ___  ___  ___   Less important 
61. It is _________________ that I will use condoms with a long time partner 
                                                       Likely ___  ___  ___  ___  ___   Unlikely 
62. Reducing my risk for HIV and other STDs  by using a condom is 
                           Extremely desirable  ___  ___  ___  ___  ___ Extremely undesirable 
63. Reducing my risk for Hepatitis C by using a condom is 
                             Extremely desirable___  ___  ___  ___  ___ Extremely undesirable 
64. The convenience of having sex without a condom is ____________ than sex with a 
condom 
                                        More desirable ___  ___  ___  ___  ___ Less desirable 
65. Regardless of the expense of condoms  it is __________ that I will still use condoms 
                                              Very Likely ___  ___  ___  ___  ___ Very Unlikely 
66. Protecting myself from STDs or pregnancy that may occur from sex without a condom 
with a casual partner is: 
                                         Very Unlikely ___  ___  ___  ___  ___  Very Likely    
 
67. My current sex partner thinks I/we __________ use condoms 
                                                     Should ___  ___  ___  ___  ___ Should not 
68. My friends think I ________________ use condoms 
                                                     Should ___  ___  ___  ___  ___ Should not 
69. Any casual sex partners I have had thought I/we _____________ use condoms 
                                                     Should ___  ___  ___  ___  ___Should not 
70. My sex partner’s opinions about condom use are important to me 
                                               Extremely ___  ___  ___  ___  ___ Not at all 
71. My friend’s opinions about condom use are important to me 
                                                Extremely ___  ___  ___   ___  ___ Not at all 
72. My casual sex partner’s opinions about condom use are important to me 
                                                Extremely ___  ___  ___  ___  ___ Not at all 
73. I am confident that I could use a condom  when I am not sober 
                                        Strongly agree ___  ___  ___  ___  ___  Strongly disagree 
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74. The decision to use condoms is beyond my control 
                                       Strongly agree ___  ___  ___  ___  ___ Strongly disagree 
75. I am confident that I could use a condom when in the heat of the moment  
                                       Strongly agree ___  ___  ___  ___  ___ Strongly disagree 
76. The resources I need to practice safer sex are not available to me 
                                       Strongly agree ___   ___  ___  ___  ___ Strongly disagree 
77. For me to use a condom when I am not sober is  
                                  Extremely likely___  ___  ___  ___  ___ Extremely unlikely 
78. Whether or not a condom is used during sex is entirely up to me 
                                     Strongly agree ___  ___   ___  ___  ___ Strongly disagree 
79. For me to use a condom when in the heat of the moment is 
                                  Extremely likely ___  ___  ___  ___  ___ Extremely Unlikely 
80. If I had the resources available I would use condoms all the time 
                                  Extremely likely ___  ___  ___  ___  ___ Extremely unlikely 
81. Overall, I think using a condom is              
                                                       Harmful ___  ___  ___  ___  ___ Beneficial   
                                                      Pleasant ___  ___  ___  ___  ___ Unpleasant   
                                 Likely for me to do  ___  ___  ___  ___  ___Unlikely for me to do 
                                       Extremely Easy  ___  ___  ___  ___  ___ Extremely Difficult 
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Past Behavior: Self Report 
 
82. I have been in drug treatment _____ times, excluding this time. 
83. In the three months prior to entering Yellowstone County Family Drug Treatment 
Court (YCFDTC) I used drugs:   
 Daily    
 Weekly (1-2 times/week)   
  Monthly (1-2 times/month) 
  Never 
84. In the three months prior to entering YCFDTC  I injected drugs: 
 Daily 
 Weekly (1-2 times/week) 
 Monthly (1-2 times/month)  
 Never 
85. In the past three months I have used drugs: 
 Daily 
 Weekly (1-2 times/week) 
 Monthly (1-2 times/month) 
 Never
86. In the past three months I injected drugs:   
 Daily 
 Weekly (1-2 times/week) 
 Monthly (1-2 times/month) 
 Never 
87. In the three months prior to entering YCFDTC I used the following drugs:
 
88. Prior to entering YCFDTC  I was arrested ______ times. 
 
89. During the past three months I have been arrested for the following charges: 
 
 
 
90. I have been tested for HIV (circle one):      yes                   no        
a. If yes, I was:      
positive                        negative 
91. I have been tested for HCV (circle one):     yes                   no        
a. If yes, I was:      
positive                        negative 
92. My risk factors for HIV/Hepatitis C include: 
 Injection Drug Use 
 Having unprotected anal sex with men 
 Having unprotected heterosexual sex 
 Not a member of a risk group
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Section 3: HIV Knowledge Questionnaire 
For each statement, please check True, False, or Don’t Know.  
If you do not know, please do not guess; instead, circle “Don’t Know.” 
1.   HIV and AIDS are the same thing.  [ ]  True [ ] False [ ] Don’t  
    Know 
2. There is a cure for AIDS.  [ ]  True [ ] False [ ] Don’t  
    Know 
3. A person can get HIV from a toilet seat. [ ]  True [ ] False [ ] Don’t  
    Know 
4. Coughing and sneezing DO NOT spread HIV.  [ ]  True [ ] False [ ] Don’t  
     Know 
5. HIV can be spread by mosquitoes.  [ ]  True [ ] False [ ] Don’t  
    Know 
6. AIDS is the cause of HIV. [ ]  True [ ] False [ ] Don’t  
    Know 
7.  A person can get HIV by sharing a glass of water 
with someone who has HIV.  
[ ]  True [ ] False [ ] Don’t    
    Know 
8. HIV is killed by bleach.  [ ]  True [ ] False [ ] Don’t  
    Know 
9.  It is possible to get HIV when a person gets a 
tattoo.  
[ ]  True [ ] False [ ] Don’t  
   Know 
10. A pregnant woman with HIV can give the virus to 
her unborn baby.  
[ ]  True [ ] False [ ] Don’t   
    Know 
11. Pulling out the penis before a man climaxes/cums 
keeps a woman from getting HIV during sex.  
[ ]  True [ ] False [ ] Don’t  
    Know 
12. A woman can get HIV if she has anal sex with a 
man.  
[ ]  True [ ] False [ ] Don’t  
   Know 
13. Showering, or washing one’s genitals/private parts, 
after sex keeps a person from getting HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
14. Eating healthy foods can keep a person from 
getting HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
15. All pregnant women infected with HIV will have 
babies born with AIDS.  
[ ]  True [ ] False [ ] Don’t  
    Know 
16. Using a latex condom or rubber can lower a 
person’s chance of getting HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
17. A person with HIV can look and feel healthy.  [ ]  True [ ] False [ ] Don’t  
    Know 
18. People who have been infected with HIV quickly 
show serious signs of being infected. 
[ ]  True [ ] False [ ] Don’t  
    Know 
19.  A person can be infected with HIV for 5 years or 
more without getting AIDS.  
[ ]  True [ ] False [ ] Don’t  
    Know 
20. There is a vaccine that can stop adults from getting 
HIV. 
[ ]  True [ ] False [ ] Don’t  
    Know 
21. Some drugs have been made for the treatment of 
AIDS.  
[ ]  True [ ] False [ ] Don’t  
    Know 
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22. Women are always tested for HIV during their pap 
smears.  
[ ]  True [ ] False [ ] Don’t  
    Know 
23.  A person cannot get HIV by having 
oral sex, mouth-to-penis, with a man who has HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
24. A person can get HIV even if she or he has sex with 
another person only one time.  
[ ]  True [ ] False [ ] Don’t  
    Know 
25.  Using a lambskin condom or rubber is the best 
protection against HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
26.  People are likely to get HIV by deep kissing, putting 
their tongue in their partner’s mouth, if their 
partner has HIV. 
[ ]  True [ ] False [ ] Don’t  
    Know 
27.  A person can get HIV by giving blood.  [ ]  True [ ] False [ ] Don’t  
    Know 
28. A woman cannot get HIV if she has sex during her 
period.  
[ ]  True [ ] False [ ] Don’t  
    Know 
29. You can usually tell if someone has HIV by looking 
at them.  
[ ]  True [ ] False [ ] Don’t  
    Know 
30.  There is a female condom that can help decrease a 
woman’s chance of getting HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
31.  A natural skin condom works better against HIV 
than does a latex condom.  
[ ]  True [ ] False [ ] Don’t  
    Know 
32.  A person will NOT get HIV if she or he is taking 
antibiotics.  
[ ]  True [ ] False [ ] Don’t  
    Know 
33.  Having sex with more than one partner can 
increase a person’s chance of being infected with 
HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
34.  Taking a test for HIV one week after having sex will 
tell a person if she or he has HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
35.  A person can get HIV by sitting in a hot tub or a 
swimming pool with a person who has HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
36.  A person can get HIV through contact with saliva, 
tears, sweat, or urine. 
[ ]  True [ ] False [ ] Don’t  
    Know 
37.  A person can get HIV from a 
woman’s vaginal secretions/wetness from her 
vagina.  
[ ]  True [ ] False [ ] Don’t  
    Know 
38. A person can get HIV if having oral sex, mouth on 
vagina, with a woman.  
[ ]  True [ ] False [ ] Don’t  
    Know 
39.  If a person tests positive for HIV, then the test site 
will have to tell all of his or her partners.  
[ ]  True [ ] False [ ] Don’t  
    Know 
40.  Using Vaseline or baby oil with condoms lowers 
the chance of getting HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
41.  Washing drug use equipment/”works” with cold 
water kills HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
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Section 4:  Hepatitis C Knowledge Test 
The following questions are true/false/don’t know and multiple choice.    
If you do not know, please do not guess; instead, circle “Don’t Know.” 
1. Hepatitis C affects which body organ? 
 Heart                                                                D.  Kidneys                
 Lungs                                                                E.  Don’t Know  
 Liver               
2. Hepatitis C is caused by ________? 
 Bacteria                                                          D.  A Fungus 
 A Virus                                                            E.  Don’t Know 
 Alcohol                   
3. If I have received vaccinations for hepatitis I no longer have to worry about 
Hepatitis C? 
 True                               B.  False                                C.  Don’t Know 
4. More people have Hepatitis C than HIV/AIDS. 
 True                               B.  False                                C.  Don’t Know 
5. Hepatitis C is spread by 
 Blood                                                              D.  Seminal/vaginal fluid 
 Saliva                                                              E.  Don’t Know 
 Eating contaminated food/water 
6. What is the most common way of getting Hepatitis C today? 
 Sexual Activity                                             D. Eating contaminated 
food/water 
 Blood Transfusions                                     E.  Don’t Know 
 Injection Drug Use 
 
 
42. A woman can get HIV if she has vaginal sex with a 
man who has HIV. 
[ ]  True [ ] False [ ] Don’t  
    Know 
43.  Athletes who share needles when using steroids 
can get HIV from the needles.  
[ ]  True [ ] False [ ] Don’t  
    Know 
44.  Douching after sex will keep a woman from getting 
HIV.  
[ ]  True [ ] False [ ] Don’t  
    Know 
45.  Taking vitamins keeps a person from getting HIV.  [ ]  True [ ] False [ ] Don’t  
    Know 
46. A person cannot get HIV by having sex with a 
person who is HIV+ but is taking anti-
retroviral drugs. 
[ ]  True [ ] False [ ] Don’t  
    Know 
47. A person cannot get HIV from a person who is 
HIV+ and has a zero viral load. 
[ ]  True [ ] False [ ] Don’t  
    Know 
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7. When having sex with someone who has Hepatitis C, you should ________. 
 Always wear a condom  
 Wear a condom if an STD or cut is present 
 Never wear a condom 
 Sometimes wear a condom 
 Don’t Know 
8. What percentage of individuals with Hepatitis C will develop chronic health 
conditions? 
 10-15%                                                           D.  80-85% 
 30-35%                                                           E.  Don’t Know 
 60-65% 
9. What is the most common symptom of chronic Hepatitis C? 
 Fatigue                                                           D.  Flu-like symptoms 
 Insomnia                                                        E.  Don’t Know 
 High blood pressure 
10. What is the most common symptom of acute Hepatitis C? 
 Fatigue                                                             D.  Flu-like symptoms 
 Insomnia                                                          E. Don’t Know 
 High blood pressure 
11. If I am diagnosed with Hepatitis C but have no symptoms I do not need to seek 
medical attention until symptoms develop? 
 True                               B.  False                                C.  Don’t Know 
12. Hepatitis C can cause _______. 
 Heart Attack                                                     D. High blood pressure 
 Stroke                                                                 E.  Don’t Know 
 Cirrhosis of the liver 
13. Antibiotics can treat Hepatitis C? 
 True                               B.  False                                C.  Don’t Know 
14. Is there a risk of transmitting Hepatitis C from an infected mother to an unborn 
child? 
 No risk  
 Yes, a potential risk exists 
 Yes, if the mother had Hepatitis C before she was pregnant 
 No, if she got Hepatitis C while she was pregnant 
 Don’t Know 
15. How long does it usually take before chronic signs or symptoms appear after 
Hepatitis C infection? 
 Within the first year                                       D.  Hepatitis C has no 
symptom 
 5-10 years                                                         E.  Don’t Know 
 20-30 years 
p 
 
16. Hepatitis C is not always life threatening? 
 True                               B.  False                                C.  Don’t Know 
17. How many people in the US are estimated to have Hepatitis C? 
 100,000                                                             D.  4 million 
 500,000                                                             E.  Don’t Know 
 1.5 million 
18. If I received a blood transfusion before 1992 I am at risk for Hepatitis C? 
 True                               B.  False                                C.  Don’t know 
19. I am at risk for Hepatitis C when I use drugs that I do not inject? 
 True                               B.  False                                C.  Don’t Know 
20. Hepatitis C can remain active and contagious for up to four days outside the 
body? 
 True                               B.  False                                C.  Don’t Know 
21. How can you determine whether or not you have Hepatitis C? 
 Tired all the time                                             D.  Urine Test 
 Constant abdominal pain                              E.  Don’t Know 
 Blood Test 
22. Touching or using the bathroom after someone with Hepatitis C puts me at risk 
for Hepatitis C? 
 True                               B.  False                                C.  Don’t know 
 
Thank you again for your time!!! 
 
 
 
101 
 
 
 
 
 
 
Appendix C 
Yellowstone County Family Drug Treatment Court: 
Participant Criteria 
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13
th
 Judicial District 
Yellowstone County Family Drug Treatment Court 
Participation Criteria 
 
The court is targeting parents whose children have been placed into the child welfare 
system due to abuse and/or neglect related to substance abuse, using the listed criteria to 
determine eligibility. 
Client must meet the following criteria to be considered for participation in YCFDTC: 
 Parent is 18 years of age or older 
 Parent has neglected/abandoned child and there are allegations of substance abuse 
 The child has been removed and the parent(s) acknowledges the removal is due to 
substance abuse-related neglect 
 Parent meets DSM-IV criteria for drug/alcohol dependence 
 Parent is able to understand and willing to comply with Participation Agreement and 
Informed Consent 
 Parent is willing to participate in Yellowstone County Family Drug Treatment Court 
 Child(ren) have been adjudicated as youth in need of care and temporary legal custody 
has been granted to DPHHS-Child and Family Services Division 
 Treatment team approval 
If client meets one or more of the following criteria, client will be ineligible for 
participation in YCFDTC: 
 Parent is not a resident of Yellowstone County, Montana 
 Parent has been convicted of a deliberate homicide or murder, kidnapping, robbery, 
felony assault or other violent felonies, sex offenses 
 Parent has another charge pending for which (s)he would be deemed ineligible 
 Parent has a medical or psychiatric condition causing a degree of impairment or 
instability such that it would interfere with program participation and functioning 
 Parent can not effectively participate in YCFDTC because of time constraints imposed by 
the Adoptions and Safe Families Act 
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Appendix D 
 
Focus Group Questions 
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Focus Group Questions 
1. What do you recall about the HIV/HCV program? 
 
2. What effect, if any, did the program have on you while you were going through 
treatment court? 
 
3. More specifically, what effect did your participation in the program have on the 
following: 
a. Your knowledge about how to prevent HIV 
b. Your knowledge about how to prevent HCV 
c. Your attitude about abstaining from drug use 
d. Your attitude about using condoms 
e. Your sense of support for abstaining from drug use from significant 
people in your life 
f. Your sense of support for using condoms from significant people in your 
life 
g. Your level of confidence that you will be able to abstain from drug use 
h. Your level of confidence that you will be able negotiate the use of 
condoms with your sexual partners 
 
4. What suggestions do you have for improving future HIV/HCV prevention 
programs? 
 
5. Do you have any additional comments that you would like to add about the 
program or anything else we’ve discussed? 
 
6. If you were to choose one thing that was most memorable or most helpful about 
the program, what would it be? 
 
7. How effective do you think the program would be if it were taught by someone 
other than Casey and Eddie? 
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Cover Letter to Participants 
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Dear Taking it to Treatment Court Participant, 
 
 
 
My name is Casey Rudd and I’ll be facilitating a program you will 
be attending called, “Taking it to Treatment Court.”  The state 
public health department wants to conduct an evaluation study of 
the program to see if it makes a difference in the lives of people 
who participate.  Therefore, we are asking you to complete the 
questionnaire enclosed in this packet.   
Enclosed you will find the Taking it to Treatment Court Evaluation 
Survey along with $10 for completing the survey.  A self addressed 
stamped envelope is also provided for you to mail your responses 
directly to the researchers at the University of Montana.  Again, all 
your answers will remain anonymous, and your identity will not be 
disclosed to the researchers at the University of Montana or facility 
of the Yellowstone County Family Drug Treatment Court.  You 
can also participant in a focus group that will be held after Taking 
it to Treatment Court has ended. Upon participation you will 
receive $20? 
 
 
 
 
Thank You, 
 
 
 
 
Casey Rudd 
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Appendix F 
 
 
Institutional Review Board Approval 
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5.  
